BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 039276
(263 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 75.5 bits (184), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 63/296 (21%)
Query: 17 SLKSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQY--GGAFKN 74
SL+ L ++++NFS N++ RGGFG +YK ++ DG V VK + GG +
Sbjct: 29 SLRELQVASDNFSN------KNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ- 81
Query: 75 LDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCL---STSNYILDFFQR 131
E M+ + H+NL+++ C + L+ M +GS+ CL S LD+ +R
Sbjct: 82 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 132 LHIMIDVASAVEYLHFGH-----------STHLLLKE-------DQSLTQI--------- 164
I + A + YLH H + ++LL E D L ++
Sbjct: 142 QRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 165 -QTLATISYMAP------------DTYNFGIMIMETFSGKKP---TIKFFHGEMTLKHWV 208
TI ++AP D + +G+M++E +G++ ++ L WV
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 209 NDLLPNSVMK-VVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
LL ++ +V +L K++ + + +A+ CT SP +R E+
Sbjct: 261 KGLLKEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEV 310
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 70/296 (23%), Positives = 125/296 (42%), Gaps = 63/296 (21%)
Query: 17 SLKSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQY--GGAFKN 74
SL+ L ++++NF N++ RGGFG +YK ++ DG V VK + GG +
Sbjct: 21 SLRELQVASDNFXN------KNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ- 73
Query: 75 LDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCL---STSNYILDFFQR 131
E M+ + H+NL+++ C + L+ M +GS+ CL S LD+ +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 132 LHIMIDVASAVEYLHFGH-----------STHLLLKE-------DQSLTQI--------- 164
I + A + YLH H + ++LL E D L ++
Sbjct: 134 QRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 165 -QTLATISYMAP------------DTYNFGIMIMETFSGKKP---TIKFFHGEMTLKHWV 208
I ++AP D + +G+M++E +G++ ++ L WV
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 209 NDLLPNSVMK-VVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
LL ++ +V +L K++ + + +A+ CT SP +R E+
Sbjct: 253 KGLLKEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 48/254 (18%)
Query: 16 TSLKSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNL 75
L L+ + NNF FL I G FG +YK ++DG +V +K + +
Sbjct: 29 VPLVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 76 DVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI---LDFFQRL 132
+ E + RH +L+ +I C + + LI + M +G+L + L S+ + + QRL
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 133 HIMIDVASAVEYLHFGHSTH-------LLLKE------------------DQSLTQIQTL 167
I I A + YLH H +LL E DQ+
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVK 202
Query: 168 ATISYMAP------------DTYNFGIMIMETFSGKKPTIKFFHGEMT-LKHWVNDLLPN 214
T+ Y+ P D Y+FG+++ E + ++ EM L W + N
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 215 SVM-KVVSANLLSR 227
+ ++V NL +
Sbjct: 263 GQLEQIVDPNLADK 276
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/283 (22%), Positives = 105/283 (37%), Gaps = 79/283 (27%)
Query: 40 ISRGGFGSIYKAK------IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
+ G FG ++ A+ +D M V VK A K+ E ++ ++H++++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLST---------------SNYILDFFQRLHIMIDV 138
C D ++ E M HG L K L + L Q LHI +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 139 ASAVEYL---HFGH----------STHLLLK------------EDQSLTQIQTLATISYM 173
AS + YL HF H +LL+K D T+ I +M
Sbjct: 143 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 202
Query: 174 AP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVV 220
P D ++FG+++ E F+ GK+P + + E+ + +
Sbjct: 203 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-------------IECIT 249
Query: 221 SANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
+L R C V+++ + C P QR+N KE+
Sbjct: 250 QGRVLER-------PRVCPKEVYDVMLGCWQREPQQRLNIKEI 285
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 48/254 (18%)
Query: 16 TSLKSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNL 75
L L+ + NNF FL I G FG +YK ++DG +V +K + +
Sbjct: 29 VPLVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 76 DVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI---LDFFQRL 132
+ E + RH +L+ +I C + + LI + M +G+L + L S+ + + QRL
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 133 HIMIDVASAVEYLHFGHSTH-------LLLKED------------------QSLTQIQTL 167
I I A + YLH H +LL E+ Q+
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVK 202
Query: 168 ATISYMAP------------DTYNFGIMIMETFSGKKPTIKFFHGEMT-LKHWVNDLLPN 214
T+ Y+ P D Y+FG+++ E + ++ EM L W + N
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 215 SVM-KVVSANLLSR 227
+ ++V NL +
Sbjct: 263 GQLEQIVDPNLADK 276
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 41/206 (19%)
Query: 26 NNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVK---GFNLQYGGAFKNLDVECNMM 82
NNF + N + GGFG +YK + + V K ++ + D E +M
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 83 KIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLS--TSNYILDFFQRLHIMIDVAS 140
+H+NL++++ S D L+ MP+GSL LS L + R I A+
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 144
Query: 141 AVEYLHFGHSTH-------LLLKE------------------DQSLTQIQTLATISYMAP 175
+ +LH H H +LL E Q++ + + T +YMAP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 176 -----------DTYNFGIMIMETFSG 190
D Y+FG++++E +G
Sbjct: 205 EALRGEITPKSDIYSFGVVLLEIITG 230
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 41/206 (19%)
Query: 26 NNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVK---GFNLQYGGAFKNLDVECNMM 82
NNF + N + GGFG +YK + + V K ++ + D E +M
Sbjct: 25 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 83 KIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLS--TSNYILDFFQRLHIMIDVAS 140
+H+NL++++ S D L+ MP+GSL LS L + R I A+
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 144
Query: 141 AVEYLHFGHSTH-------LLLKE------------------DQSLTQIQTLATISYMAP 175
+ +LH H H +LL E Q++ + + T +YMAP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 176 -----------DTYNFGIMIMETFSG 190
D Y+FG++++E +G
Sbjct: 205 EALRGEITPKSDIYSFGVVLLEIITG 230
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 41/206 (19%)
Query: 26 NNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVK---GFNLQYGGAFKNLDVECNMM 82
NNF + N + GGFG +YK + + V K ++ + D E +M
Sbjct: 19 NNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 78
Query: 83 KIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLS--TSNYILDFFQRLHIMIDVAS 140
+H+NL++++ S D L+ MP+GSL LS L + R I A+
Sbjct: 79 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 138
Query: 141 AVEYLHFGHSTH-------LLLKE------------------DQSLTQIQTLATISYMAP 175
+ +LH H H +LL E Q + + + T +YMAP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 176 -----------DTYNFGIMIMETFSG 190
D Y+FG++++E +G
Sbjct: 199 EALRGEITPKSDIYSFGVVLLEIITG 224
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 30/106 (28%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 46 GSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC--SKDD 101
G ++K + Q G ++VVK ++ K+ D EC ++I H N++ ++ +C
Sbjct: 24 GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 102 FKALILECMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLH 146
LI MP+GSL L +N+++D Q + +D+A + +LH
Sbjct: 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 46 GSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSCSKD--D 101
G ++K + Q G ++VVK ++ K+ D EC ++I H N++ ++ +C
Sbjct: 24 GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 102 FKALILECMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLH 146
LI P+GSL L +N+++D Q + +D A +LH
Sbjct: 83 HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH 128
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 60/278 (21%), Positives = 101/278 (36%), Gaps = 76/278 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
+ G FG ++ A+ QD + V VK A K+ E ++ ++H++++K
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLST------------SNYILDFFQRLHIMIDVASA 141
C + D ++ E M HG L K L L Q LHI +A+
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 142 VEYL---HFGH---STHLLLKEDQSLTQI-------------------QTLATISYMAP- 175
+ YL HF H +T L + L +I T+ I +M P
Sbjct: 141 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 200
Query: 176 -----------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++ G+++ E F+ GK+P + + E+ + +
Sbjct: 201 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------------IECITQGR 247
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAK 261
+L R C V+ L + C P+ R N K
Sbjct: 248 VLQR-------PRTCPQEVYELMLGCWQREPHMRKNIK 278
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 63/303 (20%), Positives = 108/303 (35%), Gaps = 74/303 (24%)
Query: 13 GDLTSLK--SLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQD-----GMEVVVKGFN 65
GD+ S K + ++ +F FL +L G FG + + G +V VK
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLK 59
Query: 66 LQYGGA-FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA--LILECMPHGSLGKCLSTS 122
+ GG +L E +++ + H+N++K C++D LI+E +P GSL + L +
Sbjct: 60 PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
Query: 123 NYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATIS----------- 171
++ Q+L + + ++YL H L L + + I
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
Query: 172 ---------------------------YMAPDTYNFGIMIMETF----SGKKPTIKFF-- 198
Y+A D ++FG+ + E S P F
Sbjct: 180 KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 199 ----HGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESP 254
HG+MT+ VN L +E + C V+ L +C P
Sbjct: 240 IGPTHGQMTVTRLVNTL---------------KEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 255 NQR 257
+ R
Sbjct: 285 SNR 287
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 42/195 (21%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
I G FG++++A+ G +V VK Q + E +MK +RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 98 SKDDFKALILECMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGH------ 149
++ +++ E + GSL + L S + LD +RL + DVA + YLH +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 150 ---STHLL----------------LKEDQSLTQIQTLATISYMAP------------DTY 178
S +LL LK L+ T +MAP D Y
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 179 NFGIMIMETFSGKKP 193
+FG+++ E + ++P
Sbjct: 224 SFGVILWELATLQQP 238
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 42/195 (21%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
I G FG++++A+ G +V VK Q + E +MK +RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 98 SKDDFKALILECMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGH------ 149
++ +++ E + GSL + L S + LD +RL + DVA + YLH +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 150 ---STHLL----------------LKEDQSLTQIQTLATISYMAP------------DTY 178
S +LL LK L T +MAP D Y
Sbjct: 164 DLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVY 223
Query: 179 NFGIMIMETFSGKKP 193
+FG+++ E + ++P
Sbjct: 224 SFGVILWELATLQQP 238
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 43/207 (20%)
Query: 26 NNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGF----NLQYGGAFKNLDVECNM 81
NNF + N GGFG +YK + + V VK ++ + D E +
Sbjct: 16 NNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKV 74
Query: 82 MKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLS--TSNYILDFFQRLHIMIDVA 139
+H+NL++++ S D L+ P+GSL LS L + R I A
Sbjct: 75 XAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAA 134
Query: 140 SAVEYLHFGHSTH-------LLLKE------------------DQSLTQIQTLATISYMA 174
+ + +LH H H +LL E Q + + + T +Y A
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 175 P-----------DTYNFGIMIMETFSG 190
P D Y+FG++++E +G
Sbjct: 195 PEALRGEITPKSDIYSFGVVLLEIITG 221
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 47.4 bits (111), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 43/203 (21%), Positives = 78/203 (38%), Gaps = 51/203 (25%)
Query: 39 LISRGGFGSIYKAKIQDGMEVVVKGF----NLQYGGAFKNLDVECNMMKIIRHQNLIKII 94
+I GGFG +Y+A G EV VK + +N+ E + +++H N+I +
Sbjct: 14 IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-------- 146
C K+ L++E G L + LS D ++ + +A + YLH
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPII 130
Query: 147 ---FGHSTHLLL---------------------KEDQSLTQIQTLATISYMAP------- 175
S L+L +E T++ ++MAP
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 176 -----DTYNFGIMIMETFSGKKP 193
D +++G+++ E +G+ P
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVP 213
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 112/280 (40%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL + L +D + L + +EYL H
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 140
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 201 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 252
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 253 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 285
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 52/253 (20%), Positives = 89/253 (35%), Gaps = 66/253 (26%)
Query: 56 GMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA--LILECMPH 112
G +V VK + GG +L E +++ + H+N++K C++D LI+E +P
Sbjct: 38 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 113 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATIS- 171
GSL + L + ++ Q+L + + ++YL H L L + + I
Sbjct: 98 GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 157
Query: 172 -------------------------------------YMAPDTYNFGIMIMETF----SG 190
Y+A D ++FG+ + E S
Sbjct: 158 FGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 217
Query: 191 KKPTIKFF------HGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFN 244
P F HG+MT+ VN L +E + C V+
Sbjct: 218 SSPMALFLKMIGPTHGQMTVTRLVNTL---------------KEGKRLPCPPNCPDEVYQ 262
Query: 245 LAMECTVESPNQR 257
L +C P+ R
Sbjct: 263 LMRKCWEFQPSNR 275
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 138
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 139 RNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 198
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 199 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 250
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 251 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 283
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 142
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 143 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 202
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 203 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 254
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 255 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 287
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 140
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 201 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 252
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 253 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 285
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 249
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 250 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 282
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 136
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 137 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 196
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 197 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 248
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 249 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 281
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 144
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 145 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 204
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 205 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 256
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 257 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 289
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 143
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 144 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 203
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 204 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 255
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 256 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 288
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 249
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 250 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 282
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 155
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 156 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 215
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 216 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 267
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 268 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 300
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 135
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 136 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 195
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 196 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 247
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 248 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 280
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 155
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 156 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 215
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 216 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 267
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 268 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 300
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 141
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 142 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 201
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 202 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 253
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 254 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 286
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 198 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 249
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 250 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 282
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 168
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 228
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 229 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 280
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 281 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 313
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 60/280 (21%), Positives = 111/280 (39%), Gaps = 71/280 (25%)
Query: 40 ISRGGFGSIYKAK---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
+ +G FGS+ + +QD VV LQ+ ++ + E ++K ++H N++K
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 95 SSCSKDDFK--ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL------H 146
C + LI+E +P+GSL L +D + L + +EYL H
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIH 140
Query: 147 FGHSTHLLLKEDQSLTQIQTL--------------------ATISYMAP----------- 175
+T +L E+++ +I + I + AP
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 176 -DTYNFGIMIMETFS----GKKPTIKFF-------HGEMTLKHWVNDLLPNSVMKVVSAN 223
D ++FG+++ E F+ K P +F G+M + H + +LL N+
Sbjct: 201 SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-ELLKNN-------G 252
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R D C ++ + EC + NQR + +++
Sbjct: 253 RLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 285
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/282 (20%), Positives = 102/282 (36%), Gaps = 78/282 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
+ G FG ++ A+ QD M V VK A ++ E ++ +++HQ++++
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLST--------------SNYILDFFQRLHIMIDVA 139
C++ ++ E M HG L + L + + L Q L + VA
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 140 SAVEY---LHFGH----------STHLLLK------------EDQSLTQIQTLATISYMA 174
+ + Y LHF H L++K D +T+ I +M
Sbjct: 140 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 199
Query: 175 P------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVS 221
P D ++FG+++ E F+ GK+P + S + +
Sbjct: 200 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----------------SNTEAID 242
Query: 222 ANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
RE E C V+ + C P QR + K++
Sbjct: 243 CITQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDV 281
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/282 (19%), Positives = 103/282 (36%), Gaps = 78/282 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
+ G FG ++ A+ QD M V VK A ++ E ++ +++HQ++++
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLST--------------SNYILDFFQRLHIMIDVA 139
C++ ++ E M HG L + L + + L Q L + VA
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 140 SAVEY---LHFGH----------STHLLLK------------EDQSLTQIQTLATISYMA 174
+ + Y LHF H L++K D +T+ I +M
Sbjct: 146 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 205
Query: 175 P------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVS 221
P D ++FG+++ E F+ GK+P + + E ++ +
Sbjct: 206 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------------AIDCITQ 252
Query: 222 ANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
L R C V+ + C P QR + K++
Sbjct: 253 GRELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDV 287
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/282 (20%), Positives = 102/282 (36%), Gaps = 78/282 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
+ G FG ++ A+ QD M V VK A ++ E ++ +++HQ++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLST--------------SNYILDFFQRLHIMIDVA 139
C++ ++ E M HG L + L + + L Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 140 SAVEY---LHFGH----------STHLLLK------------EDQSLTQIQTLATISYMA 174
+ + Y LHF H L++K D +T+ I +M
Sbjct: 169 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 228
Query: 175 P------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVS 221
P D ++FG+++ E F+ GK+P + S + +
Sbjct: 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----------------SNTEAID 271
Query: 222 ANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
RE E C V+ + C P QR + K++
Sbjct: 272 CITQGRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDV 310
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 49/201 (24%)
Query: 37 SNLISRGGFGSIYKAKIQDGMEV----VVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 92
S I G FG++YK K + V VV Q+ AF+N E +++ RH N++
Sbjct: 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ-AFRN---EVAVLRKTRHVNILL 96
Query: 93 IISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 152
+ +KD+ A++ + SL K L FQ + I A ++YLH + H
Sbjct: 97 FMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIH 155
Query: 153 LLLKED-----QSLT-------------------QI-QTLATISYMAP------------ 175
+K + + LT Q+ Q ++ +MAP
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 176 ---DTYNFGIMIMETFSGKKP 193
D Y++GI++ E +G+ P
Sbjct: 216 FQSDVYSYGIVLYELMTGELP 236
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/265 (21%), Positives = 90/265 (33%), Gaps = 74/265 (27%)
Query: 40 ISRGGFGSIYKAKIQ-DGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIKIISSC 97
I RG FG ++ +++ D V VK K E ++K H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKE 157
++ +++E + G L T L L ++ D A+ +EYL H L
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 158 DQSLTQIQTLATIS-------------------------YMAP------------DTYNF 180
L + + IS + AP D ++F
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 181 GIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTK---- 235
GI++ ETFS G P NL +++ F+ K
Sbjct: 302 GILLWETFSLGASPY---------------------------PNLSNQQTREFVEKGGRL 334
Query: 236 ---EQCMSFVFNLAMECTVESPNQR 257
E C VF L +C P QR
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQR 359
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/265 (21%), Positives = 90/265 (33%), Gaps = 74/265 (27%)
Query: 40 ISRGGFGSIYKAKIQ-DGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIKIISSC 97
I RG FG ++ +++ D V VK K E ++K H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKE 157
++ +++E + G L T L L ++ D A+ +EYL H L
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241
Query: 158 DQSLTQIQTLATIS-------------------------YMAP------------DTYNF 180
L + + IS + AP D ++F
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 181 GIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTK---- 235
GI++ ETFS G P NL +++ F+ K
Sbjct: 302 GILLWETFSLGASPY---------------------------PNLSNQQTREFVEKGGRL 334
Query: 236 ---EQCMSFVFNLAMECTVESPNQR 257
E C VF L +C P QR
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQR 359
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 45.1 bits (105), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 58/225 (25%)
Query: 43 GGFGSIYKAKIQD---GMEVVVKGFNL---QYGGAFKNLDVECNMMKIIRHQNLIKIISS 96
GG ++Y A +D ++V +K + + K + E + + HQN++ +I
Sbjct: 22 GGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79
Query: 97 CSKDDFKALILECMP----------HG--SLGKCLSTSNYILDFFQRLH----------- 133
+DD L++E + HG S+ ++ +N ILD + H
Sbjct: 80 DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKP 139
Query: 134 --IMIDVASAVEYLHFGHSTHLLLKEDQSLTQI-QTLATISYMAP------------DTY 178
I+ID ++ FG + L + SLTQ L T+ Y +P D Y
Sbjct: 140 QNILIDSNKTLKIFDFGIAKAL---SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIY 196
Query: 179 NFGIMIMETFSGKKPTIKFFHGE----MTLKHWVNDLLPNSVMKV 219
+ GI++ E G+ P F+GE + +KH + D +PN V
Sbjct: 197 SIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV 236
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 54/268 (20%), Positives = 105/268 (39%), Gaps = 70/268 (26%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNL-------QYGGAFKNLDVECNMMKIIRHQNLI 91
I +GGFG ++K + ++D V +K L + F+ E +M + H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG--- 148
K+ +++E +P G L L + + + +L +M+D+A +EY+
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 149 ------HSTHLLLKE------------DQSLTQIQTLATIS-------YMAP-------- 175
S ++ L+ D SL+Q Q++ ++S +MAP
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-QSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 176 ------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSRED 229
DTY+F +++ +G+ P ++ +G K+ N++ E
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYG-----------------KIKFINMIREEG 246
Query: 230 EHFMTKEQCMSFVFNLAMECTVESPNQR 257
E C + N+ C P +R
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKR 274
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 78/190 (41%), Gaps = 38/190 (20%)
Query: 40 ISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G G++Y A + G EV ++ NLQ + + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + GSL ++ + +D Q + + A+E+LH H +K D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 159 QSL---------------TQI--------QTLATISYMAP------------DTYNFGIM 183
L QI + + T +MAP D ++ GIM
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 184 IMETFSGKKP 193
+E G+ P
Sbjct: 206 AIEMIEGEPP 215
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 38/190 (20%)
Query: 40 ISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G G++Y A + G EV ++ NLQ + + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + GSL ++ + +D Q + + A+E+LH H +K D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L QI + T +MAP D ++ GIM
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 184 IMETFSGKKP 193
+E G+ P
Sbjct: 206 AIEMIEGEPP 215
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 38/190 (20%)
Query: 40 ISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G G++Y A + G EV ++ NLQ + + E +M+ ++ N++ + S
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + GSL ++ + +D Q + + A+E+LH H +K D
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 146
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L QI + T +MAP D ++ GIM
Sbjct: 147 NILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 206
Query: 184 IMETFSGKKP 193
+E G+ P
Sbjct: 207 AIEMIEGEPP 216
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 38/190 (20%)
Query: 40 ISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G G++Y A + G EV ++ NLQ + + E +M+ ++ N++ + S
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + GSL ++ + +D Q + + A+E+LH H +K D
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSD 146
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L QI + T +MAP D ++ GIM
Sbjct: 147 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 206
Query: 184 IMETFSGKKP 193
+E G+ P
Sbjct: 207 AIEMIEGEPP 216
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 38/190 (20%)
Query: 40 ISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G G++Y A + G EV ++ NLQ + + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + GSL ++ + +D Q + + A+E+LH H +K D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L QI + T +MAP D ++ GIM
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 184 IMETFSGKKP 193
+E G+ P
Sbjct: 206 AIEMIEGEPP 215
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 66/235 (28%)
Query: 72 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLG-----KCLSTSNYIL 126
++ +V C + + + Q L I S CS D ++ PH +G + + ++
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 127 DFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ--------------------- 165
DF +H++ +A+ +EYL H H L L +
Sbjct: 129 DF---VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 166 ----TLATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWV 208
+L I +MAP D +++G+++ E FS G +P +
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----------- 234
Query: 209 NDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
S VV + R + + C ++V+ L +EC E P++R K++
Sbjct: 235 ------SNQDVVE---MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/135 (21%), Positives = 64/135 (47%), Gaps = 8/135 (5%)
Query: 34 FSESNLISRGGFGSIYKAK-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQN 89
F NL+ +G F +Y+A+ I G+EV +K + + G + + E + ++H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 149
++++ + ++ L+LE +G + + L + H M + + + YLH
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 150 STHLLLKEDQSLTQI 164
+H +L D +L+ +
Sbjct: 130 -SHGILHRDLTLSNL 143
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 20 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 74
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG------ 148
+K A++ + SL L S + + + I A ++YLH
Sbjct: 75 GYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 133
Query: 149 -HSTHLLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
S ++ L ED ++ Q + L+ +I +MAP
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 194 SDVYAFGIVLYELMTGQLP 212
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 37/134 (27%), Positives = 57/134 (42%), Gaps = 32/134 (23%)
Query: 38 NLISRGGFGSIYKAKIQ-DGM----------EVVVKGFNLQYGGAFKNLDVECNMMKIIR 86
++I G FG + KA+I+ DG+ E K + + G L+V C K+
Sbjct: 21 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLC---KLGH 74
Query: 87 HQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI---------------LDFFQR 131
H N+I ++ +C + L +E PHG+L L S + L Q
Sbjct: 75 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 132 LHIMIDVASAVEYL 145
LH DVA ++YL
Sbjct: 135 LHFAADVARGMDYL 148
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 37/134 (27%), Positives = 57/134 (42%), Gaps = 32/134 (23%)
Query: 38 NLISRGGFGSIYKAKIQ-DGM----------EVVVKGFNLQYGGAFKNLDVECNMMKIIR 86
++I G FG + KA+I+ DG+ E K + + G L+V C K+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLC---KLGH 84
Query: 87 HQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI---------------LDFFQR 131
H N+I ++ +C + L +E PHG+L L S + L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 132 LHIMIDVASAVEYL 145
LH DVA ++YL
Sbjct: 145 LHFAADVARGMDYL 158
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 60 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T Y AP F I
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPI 177
Query: 183 MIM--ETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQ 237
E+ + K +IK + G + + + P + + L +D E
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 237
Query: 238 CMSFVFNLAMECTVESPNQRINAKEM 263
C V+ L C +P+ R + E+
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 86
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG------ 148
+K A++ + SL L S + + + I A ++YLH
Sbjct: 87 GYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 149 -HSTHLLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
S ++ L ED ++ Q + L+ +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 37/134 (27%), Positives = 57/134 (42%), Gaps = 32/134 (23%)
Query: 38 NLISRGGFGSIYKAKIQ-DGM----------EVVVKGFNLQYGGAFKNLDVECNMMKIIR 86
++I G FG + KA+I+ DG+ E K + + G L+V C K+
Sbjct: 28 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLC---KLGH 81
Query: 87 HQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI---------------LDFFQR 131
H N+I ++ +C + L +E PHG+L L S + L Q
Sbjct: 82 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 132 LHIMIDVASAVEYL 145
LH DVA ++YL
Sbjct: 142 LHFAADVARGMDYL 155
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 61 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T Y AP F I
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPI 178
Query: 183 MIM--ETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQ 237
E+ + K +IK + G + + + P + + L +D E
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 238 CMSFVFNLAMECTVESPNQRINAKEM 263
C V+ L C +P+ R + E+
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I+E M +G+L L N ++ L++
Sbjct: 60 EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 120 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 239
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEI 263
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I+E M +G+L L N ++ L++
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 66/235 (28%)
Query: 72 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLG-----KCLSTSNYIL 126
++ +V C + + + Q L I S CS D ++ PH +G + + ++
Sbjct: 86 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 145
Query: 127 DFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ--------------------- 165
DF +H++ +A+ +EYL H H L L +
Sbjct: 146 DF---VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 202
Query: 166 ----TLATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWV 208
+L I +MAP D +++G+++ E FS G +P +
Sbjct: 203 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----------- 251
Query: 209 NDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
S VV + R + + C ++V+ L +EC E P++R K++
Sbjct: 252 ------SNQDVVE---MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 54/267 (20%), Positives = 103/267 (38%), Gaps = 68/267 (25%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNL-------QYGGAFKNLDVECNMMKIIRHQNLI 91
I +GGFG ++K + ++D V +K L + F+ E +M + H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 151
K+ +++E +P G L L + + + +L +M+D+A +EY+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 152 --HLLLKED----QSL--------------TQIQTLATIS-------YMAP--------- 175
H L+ QSL T Q++ ++S +MAP
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIGAEEES 204
Query: 176 -----DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDE 230
DTY+F +++ +G+ P ++ +G K+ N++ E
Sbjct: 205 YTEKADTYSFAMILYTILTGEGPFDEYSYG-----------------KIKFINMIREEGL 247
Query: 231 HFMTKEQCMSFVFNLAMECTVESPNQR 257
E C + N+ C P +R
Sbjct: 248 RPTIPEDCPPRLRNVIELCWSGDPKKR 274
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 263 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 322
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 323 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 382
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 383 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 442
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 443 EKVYELMRACWQWNPSDRPSFAEI 466
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I+E M +G+L L N + L++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I+E M +G+L L N + L++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 65/268 (24%)
Query: 35 SESNLISRGGFGSIYKAKIQDG---MEVVVKGFNLQYGGAFKN-LDV--ECNMMKIIRHQ 88
+ +I G FG +YK ++ EV V L+ G K +D E +M H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 89 NLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL--- 145
N+I++ SK +I E M +G+L K L + Q + ++ +A+ ++YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 146 -----------------------HFGHSTHLLLKEDQSLTQIQTLATISYMAP------- 175
FG S L + + T I + AP
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 176 -----DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSRED 229
D ++FGI++ E + G++P +W +L + VMK ++
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP------------YW--ELSNHEVMKAINDGF----- 267
Query: 230 EHFMTKEQCMSFVFNLAMECTVESPNQR 257
T C S ++ L M+C + +R
Sbjct: 268 -RLPTPMDCPSAIYQLMMQCWQQERARR 294
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 61/300 (20%), Positives = 103/300 (34%), Gaps = 74/300 (24%)
Query: 8 LRNSIGDLTSLKSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQ 67
LRN LK LD + +F + G +GS+YKA ++ ++V
Sbjct: 7 LRNP--PRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIV------- 57
Query: 68 YGGAFKNLDVECNMMKIIRH---------QNLIKIISSCSKDDFKALILECMPHGSLGKC 118
A K + VE ++ +II+ +++K S K+ +++E GS+
Sbjct: 58 ---AIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 119 LSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKE--------------------- 157
+ N L + I+ +EYLHF H +K
Sbjct: 115 IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174
Query: 158 --DQSLTQIQTLATISYMAP------------DTYNFGIMIMETFSGKKPTIKFFHGEMT 203
D + + T +MAP D ++ GI +E GK P
Sbjct: 175 LTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP---------- 224
Query: 204 LKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINAKEM 263
D+ P + ++ N F E + +C V+SP QR A ++
Sbjct: 225 ----YADIHPMRAIFMIPTN----PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 41.2 bits (95), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 53/268 (19%), Positives = 104/268 (38%), Gaps = 70/268 (26%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNL-------QYGGAFKNLDVECNMMKIIRHQNLI 91
I +GGFG ++K + ++D V +K L + F+ E +M + H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG--- 148
K+ +++E +P G L L + + + +L +M+D+A +EY+
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 149 ------HSTHLLLKE------------DQSLTQIQTLATIS-------YMAP-------- 175
S ++ L+ D L+Q Q++ ++S +MAP
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPETIGAEEE 203
Query: 176 ------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSRED 229
DTY+F +++ +G+ P ++ +G K+ N++ E
Sbjct: 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYG-----------------KIKFINMIREEG 246
Query: 230 EHFMTKEQCMSFVFNLAMECTVESPNQR 257
E C + N+ C P +R
Sbjct: 247 LRPTIPEDCPPRLRNVIELCWSGDPKKR 274
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 365 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 424
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 425 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 484
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 485 EKVYELMRACWQWNPSDRPSFAEI 508
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 40.8 bits (94), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 50/85 (58%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ G AFKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-GKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPE 103
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 40.8 bits (94), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 50/85 (58%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ G AFKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-GKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPE 103
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 40.4 bits (93), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 50/84 (59%), Gaps = 9/84 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ G AFKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-GKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMP 111
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVP 102
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 72 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 132 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 191
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 192 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 251
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 252 EKVYELMRACWQWNPSDRPSFAEI 275
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 242
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEI 266
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 61 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 240
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N + L++
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 385
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEI 469
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I+E M +G+L L N + L++
Sbjct: 57 EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + L +D E C
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCP 236
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEI 260
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N ++ L++
Sbjct: 61 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 121 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 240
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEI 264
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 6/120 (5%)
Query: 33 LFSESNLI-----SRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV-ECNMMKIIR 86
+F S+LI +G FG K ++ EV+V +++ + + E +M+ +
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 87 HQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 146
H N++K I KD I E + G+L + + + + QR+ D+AS + YLH
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N + L++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N + L++
Sbjct: 64 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 124 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 243
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N + L++
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL +F H HL+ D L+++ T T + A +
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + + L +D E C
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/196 (20%), Positives = 78/196 (39%), Gaps = 41/196 (20%)
Query: 39 LISRGGFGSIYKAK-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
++ +G +G +Y + + + + + +K + + L E + K ++H+N+++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 98 SKDDFKALILECMPHGSLGKCL-STSNYILDFFQRLHIMI-DVASAVEYLHFGHSTHLLL 155
S++ F + +E +P GSL L S + D Q + + ++YLH H +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 156 KEDQSLTQIQT------------------------LATISYMAP--------------DT 177
K D L + T+ YMAP D
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208
Query: 178 YNFGIMIMETFSGKKP 193
++ G I+E +GK P
Sbjct: 209 WSLGCTIIEMATGKPP 224
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 78/195 (40%), Gaps = 45/195 (23%)
Query: 38 NLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
++ RG FG + KAK + +V +K ++ K VE + + H N++K+ +C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIM---IDVASAVEYLHFGHSTHLL 154
L++E GSL L + L ++ H M + + V YLH L+
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 155 LKEDQ-------------------SLTQIQTLAT-----ISYMAP------------DTY 178
++ + + IQT T ++MAP D +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 179 NFGIMIMETFSGKKP 193
++GI++ E + +KP
Sbjct: 188 SWGIILWEVITRRKP 202
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 86
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG------ 148
+ A++ + SL L S + + + I A ++YLH
Sbjct: 87 GYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 149 -HSTHLLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
S ++ L ED ++ Q + L+ +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 40/196 (20%), Positives = 78/196 (39%), Gaps = 41/196 (20%)
Query: 39 LISRGGFGSIYKAK-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
++ +G +G +Y + + + + + +K + + L E + K ++H+N+++ + S
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 98 SKDDFKALILECMPHGSLGKCL-STSNYILDFFQRLHIMI-DVASAVEYLHFGHSTHLLL 155
S++ F + +E +P GSL L S + D Q + + ++YLH H +
Sbjct: 75 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 134
Query: 156 KEDQSLTQIQT------------------------LATISYMAP--------------DT 177
K D L + T+ YMAP D
Sbjct: 135 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 194
Query: 178 YNFGIMIMETFSGKKP 193
++ G I+E +GK P
Sbjct: 195 WSLGCTIIEMATGKPP 210
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 78/195 (40%), Gaps = 45/195 (23%)
Query: 38 NLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
++ RG FG + KAK + +V +K ++ K VE + + H N++K+ +C
Sbjct: 15 EVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIM---IDVASAVEYLHFGHSTHLL 154
L++E GSL L + L ++ H M + + V YLH L+
Sbjct: 72 LNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 155 LKEDQ-------------------SLTQIQTLAT-----ISYMAP------------DTY 178
++ + + IQT T ++MAP D +
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 188
Query: 179 NFGIMIMETFSGKKP 193
++GI++ E + +KP
Sbjct: 189 SWGIILWEVITRRKP 203
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 50/243 (20%), Positives = 94/243 (38%), Gaps = 50/243 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDD 101
G FG ++ A +V VK ++ G + + E N+MK ++H L+K+ + +K+
Sbjct: 193 GQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 250
Query: 102 FKALILECMPHGSLGKCLSTSN-------YILDFFQRLHIMIDVASAVEYLHFG-HSTHL 153
+I E M GSL L + ++DF ++ + Y+H + ++
Sbjct: 251 I-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 309
Query: 154 LLK-------EDQSLTQIQTLATISYMAP------------DTYNFGIMIMETFSGKKPT 194
L+ D L ++ I + AP D ++FGI++ME +
Sbjct: 310 LVSASLVCKIADFGLARVGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT----- 364
Query: 195 IKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESP 254
+G + N P + + + R E C ++N+ M C P
Sbjct: 365 ----YGRIPYPGMSN---PEVIRALERGYRMPR-------PENCPEELYNIMMRCWKNRP 410
Query: 255 NQR 257
+R
Sbjct: 411 EER 413
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 70
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 71 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 41/138 (29%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 16 TSLKSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNL 75
S SLDL N L L LI RG +G++YK + D V VK F+ F N
Sbjct: 5 ASEPSLDLDN-----LKLLE---LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN- 54
Query: 76 DVECNMMKI--IRHQNLIKIISSCSKDDFKA-----LILECMPHGSLGKCLSTSNYILDF 128
E N+ ++ + H N+ + I + L++E P+GSL K LS + D+
Sbjct: 55 --EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDW 110
Query: 129 FQRLHIMIDVASAVEYLH 146
+ V + YLH
Sbjct: 111 VSSCRLAHSVTRGLAYLH 128
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N + L++
Sbjct: 57 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 137 DVASAVEYLH---FGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL F H HL+ D L+++ T T + A +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKW 176
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + L +D E C
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCP 236
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEI 260
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 18 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 72
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 73 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 131
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 192 SDVYAFGIVLYELMTGQLP 210
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 36 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 90
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 91 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 149
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 210 SDVYAFGIVLYELMTGQLP 228
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 70
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 71 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 75
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 76 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 195 SDVYAFGIVLYELMTGQLP 213
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 46/207 (22%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 97
+ G FG + K + +V VK G+ + E M + H L+K C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH----------- 146
SK+ ++ E + +G L L + L+ Q L + DV + +L
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 147 ---------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYN 179
FG + ++L +DQ ++ + T + + AP D +
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 180 FGIMIMETFS-GKKPTIKFFHGEMTLK 205
FGI++ E FS GK P + + E+ LK
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLK 217
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 75
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 76 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 195 SDVYAFGIVLYELMTGQLP 213
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 43 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 97
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 98 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 156
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 217 SDVYAFGIVLYELMTGQLP 235
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 98
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 99 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 218 SDVYAFGIVLYELMTGQLP 236
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 98
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+K A++ + SL L + + + I A ++YLH H
Sbjct: 99 GYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 218 SDVYAFGIVLYELMTGQLP 236
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 18/204 (8%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMI 136
E +MK I+H NL++++ C+++ +I E M +G+L L N + L++
Sbjct: 57 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 137 DVASAVEYLH---FGH-----------STHLLLKEDQSLTQIQTLATISYMAPDTYNFGI 182
++SA+EYL F H HL+ D L+++ T T + A +
Sbjct: 117 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 183 MIMETFSGKKPTIK---FFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCM 239
E+ + K +IK + G + + + P + L +D E C
Sbjct: 177 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCP 236
Query: 240 SFVFNLAMECTVESPNQRINAKEM 263
V+ L C +P+ R + E+
Sbjct: 237 EKVYELMRACWQWNPSDRPSFAEI 260
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 7/136 (5%)
Query: 28 FSGLFLFSESNLISRGGFGSIYKAK-IQDGMEVVVKG---FNLQYGGAFKNLDVECNMMK 83
++ L F I RG F +Y+A + DG+ V +K F+L A + E +++K
Sbjct: 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 84 IIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCL---STSNYILDFFQRLHIMIDVAS 140
+ H N+IK +S +D+ ++LE G L + + ++ + + S
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 141 AVEYLHFGHSTHLLLK 156
A+E++H H +K
Sbjct: 148 ALEHMHSRRVMHRDIK 163
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 41/156 (26%), Positives = 77/156 (49%), Gaps = 22/156 (14%)
Query: 9 RNSIGDLTSLKSL--DLSNN-NFSGLFLFSESNL---------ISRGGFGSIYKAKIQDG 56
R I + T+LK L D++ + + SGL L + + I +G FG +++ K + G
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-G 65
Query: 57 MEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK----ALILECMP 111
EV VK F+ + F+ ++ +M +RH+N++ I++ +KD+ L+ +
Sbjct: 66 EEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNKDNGTWTQLWLVSDYHE 123
Query: 112 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 147
HGSL L + Y + + + + AS + +LH
Sbjct: 124 HGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 157
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 37.7 bits (86), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 47/211 (22%), Positives = 77/211 (36%), Gaps = 51/211 (24%)
Query: 29 SGLFLFSESNL-----ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNM 81
SG ++ S L I G FG ++ + +V +K GA D E +
Sbjct: 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEV 58
Query: 82 MKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 141
M + H L+++ C + L+ E M HG L L T + L + +DV
Sbjct: 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 118
Query: 142 VEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP 175
+ YL FG + +L +DQ + T + + +P
Sbjct: 119 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASP 176
Query: 176 ------------DTYNFGIMIMETFS-GKKP 193
D ++FG+++ E FS GK P
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNY-ILDFFQRLHIMI 136
E +MK I+H NL++++ C+ + ++ E MP+G+L L N + L++
Sbjct: 78 EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 137 DVASAVEYL---HFGH-----------STHLLLKEDQSLTQIQTLAT----------ISY 172
++SA+EYL +F H H++ D L+++ T T I +
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKW 197
Query: 173 MAPDTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHF 232
AP++ + TFS K F G + + + P + + L +
Sbjct: 198 TAPESLAYN-----TFSIKSDVWAF--GVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRM 250
Query: 233 MTKEQCMSFVFNLAMECTVESPNQRINAKE 262
E C V+ L C SP R + E
Sbjct: 251 EQPEGCPPKVYELMRACWKWSPADRPSFAE 280
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/202 (20%), Positives = 76/202 (37%), Gaps = 48/202 (23%)
Query: 34 FSESNLISRGGFGSIYKAKIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ 88
F + +G FG++Y A+ ++ ++V+ K L+ G L E + +RH
Sbjct: 10 FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHLRHP 68
Query: 89 NLIKIISSCSKDDFKALILECMPHGSLGKCLS---------TSNYILDFFQRL------- 132
N++++ LILE P G++ + L T+ YI + L
Sbjct: 69 NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 133 ---------HIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAP-------- 175
++++ A ++ FG S H S + T+ Y+ P
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHA-----PSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 176 ----DTYNFGIMIMETFSGKKP 193
D ++ G++ E GK P
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPP 205
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 16/150 (10%)
Query: 7 SLRNSIGDLTSLKSLD----LSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVK 62
+L++ I D+T+ S L + + ES I +G FG +++ K + G EV VK
Sbjct: 2 TLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQES--IGKGRFGEVWRGKWR-GEEVAVK 58
Query: 63 GFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK----ALILECMPHGSLGK 117
F+ + F+ ++ +M +RH+N++ I++ +KD+ L+ + HGSL
Sbjct: 59 IFSSREERSWFREAEIYQTVM--LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 116
Query: 118 CLSTSNYILDFFQRLHIMIDVASAVEYLHF 147
L + Y + + + + AS + +LH
Sbjct: 117 YL--NRYTVTVEGMIKLALSTASGLAHLHM 144
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 51/199 (25%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIKII 94
I G FG++YK K +V VK N+ Q AFKN E +++ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHVNILLFM 70
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-- 152
+ A++ + SL L + + + I A ++YLH H
Sbjct: 71 GYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 153 -----LLLKEDQSLT-----------------QIQTLA-TISYMAP-------------- 175
+ L ED ++ Q + L+ +I +MAP
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 176 -DTYNFGIMIMETFSGKKP 193
D Y FGI++ E +G+ P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 79 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 135
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHAS 195
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 236
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 71/195 (36%), Gaps = 46/195 (23%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 97
I G FG ++ + +V +K GA D E +M + H L+++ C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH----------- 146
+ L+ E M HG L L T + L + +DV + YL
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 129
Query: 147 ---------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYN 179
FG + +L +DQ + T + + +P D ++
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 180 FGIMIMETFS-GKKP 193
FG+++ E FS GK P
Sbjct: 188 FGVLMWEVFSEGKIP 202
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 71/195 (36%), Gaps = 46/195 (23%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 97
I G FG ++ + +V +K GA D E +M + H L+++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH----------- 146
+ L+ E M HG L L T + L + +DV + YL
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 131
Query: 147 ---------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYN 179
FG + +L +DQ + T + + +P D ++
Sbjct: 132 RNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 180 FGIMIMETFS-GKKP 193
FG+++ E FS GK P
Sbjct: 190 FGVLMWEVFSEGKIP 204
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 37.0 bits (84), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 71/195 (36%), Gaps = 46/195 (23%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 97
I G FG ++ + +V +K GA D E +M + H L+++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH----------- 146
+ L+ E M HG L L T + L + +DV + YL
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAA 131
Query: 147 ---------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYN 179
FG + +L +DQ + T + + +P D ++
Sbjct: 132 RNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 180 FGIMIMETFS-GKKP 193
FG+++ E FS GK P
Sbjct: 190 FGVLMWEVFSEGKIP 204
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 37.0 bits (84), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 89 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 145
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHAS 205
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 206 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 246
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 247 PEDCPQDIYNVMVQCWAHKPEDR 269
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 37.0 bits (84), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 10/85 (11%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++ +I G FG +++AK+ + EV +K LQ FKN E +M+I++H N++ +
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQ-DKRFKNR--ELQIMRIVKHPNVVDL 97
Query: 94 ----ISSCSKDD--FKALILECMPH 112
S+ K D F L+LE +P
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE 122
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 37.0 bits (84), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G FG +++ K + G EV VK F+ + F+ ++ +M +RH+N++ I++ +
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 68
Query: 99 KDDFK----ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 147
KD+ L+ + HGSL L + Y + + + + AS + +LH
Sbjct: 69 KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 119
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 37.0 bits (84), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 23 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 83 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 139
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 140 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 199
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 200 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 240
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 241 PEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 36.6 bits (83), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 79 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 135
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 236
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 36.6 bits (83), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G FG +++ K + G EV VK F+ + F+ ++ +M +RH+N++ I++ +
Sbjct: 14 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 70
Query: 99 KDDFK----ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 147
KD+ L+ + HGSL L + Y + + + + AS + +LH
Sbjct: 71 KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 121
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 36.6 bits (83), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 43/195 (22%), Positives = 71/195 (36%), Gaps = 46/195 (23%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 97
I G FG ++ + +V +K GA D E +M + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH----------- 146
+ L+ E M HG L L T + L + +DV + YL
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132
Query: 147 ---------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYN 179
FG + +L +DQ + T + + +P D ++
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 180 FGIMIMETFS-GKKP 193
FG+++ E FS GK P
Sbjct: 191 FGVLMWEVFSEGKIP 205
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 36.6 bits (83), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G FG +++ K + G EV VK F+ + F+ ++ +M +RH+N++ I++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 67
Query: 99 KDDFK----ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 147
KD+ L+ + HGSL L + Y + + + + AS + +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 118
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 36.6 bits (83), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I +G FG +++ K + G EV VK F+ + F+ ++ +M +RH+N++ I++ +
Sbjct: 17 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 73
Query: 99 KDDFK----ALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 147
KD+ L+ + HGSL L + Y + + + + AS + +LH
Sbjct: 74 KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHM 124
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 36.6 bits (83), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 79 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 135
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 195
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 196 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 236
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 36.6 bits (83), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 23 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 82
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 83 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 139
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 140 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 199
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 200 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 240
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 241 PEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 36.6 bits (83), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 54/263 (20%), Positives = 88/263 (33%), Gaps = 70/263 (26%)
Query: 43 GGFGSI----YKAKIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 95
G FG + + A + V VK L A + E N M + H+NLI++
Sbjct: 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 96 SCSKDDFKALILECMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLH------- 146
K ++ E P GSL L +++L R + VA + YL
Sbjct: 89 VVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRFIHR 145
Query: 147 -------------------FGHSTHLLLKEDQSLTQIQTLATISYMAP------------ 175
FG L +D + Q ++ AP
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHAS 205
Query: 176 DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMT 234
DT+ FG+ + E F+ G++P I ++ K + +E E
Sbjct: 206 DTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-------------------IDKEGERLPR 246
Query: 235 KEQCMSFVFNLAMECTVESPNQR 257
E C ++N+ ++C P R
Sbjct: 247 PEDCPQDIYNVMVQCWAHKPEDR 269
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 34/155 (21%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 33 LFSESNLISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQN 89
LF E + +G F + + KI G E K N + A + L+ E + ++++H N
Sbjct: 8 LFEE---LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 149
++++ S S++ F L+ + + G L + + Y + H + + +V + H
Sbjct: 65 IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-ADASHCIQQILESVNHCHLNG 123
Query: 150 STHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMI 184
H LK + L ++ +A +FG+ I
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLA----DFGLAI 154
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 36.2 bits (82), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 40/183 (21%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 13 GDLTSLKSLDLSNNNFS--GLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG 70
G SLK D++ F LFS+ I G FG++Y A+ EVV + Y G
Sbjct: 33 GRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIK-KMSYSG 91
Query: 71 -----AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI 125
++++ E ++ +RH N I+ ++ L++E CL +++ +
Sbjct: 92 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY--------CLGSASDL 143
Query: 126 LDFFQRLHIMIDVAS----AVEYLHFGHSTHLLLKE---------DQSLTQIQTLATISY 172
L+ ++ +++A+ A++ L + HS +++ ++ + L ++ + S
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 173 MAP 175
MAP
Sbjct: 204 MAP 206
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 36.2 bits (82), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 34/155 (21%), Positives = 57/155 (36%), Gaps = 41/155 (26%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMID 137
E +M + H L+++ C + L+ E M HG L L T + L + +D
Sbjct: 72 EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 138 VASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATIS 171
V + YL FG + +L +DQ + T +
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVK 189
Query: 172 YMAP------------DTYNFGIMIMETFS-GKKP 193
+ +P D ++FG+++ E FS GK P
Sbjct: 190 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 224
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 36.2 bits (82), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 34/155 (21%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 33 LFSESNLISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQN 89
LF E + +G F + + KI G E K N + A + L+ E + ++++H N
Sbjct: 8 LFEE---LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 149
++++ S S++ F L+ + + G L + + Y + H + + +V + H
Sbjct: 65 IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-ADASHCIQQILESVNHCHLNG 123
Query: 150 STHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMI 184
H LK + L ++ +A +FG+ I
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLA----DFGLAI 154
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 36.2 bits (82), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 49/255 (19%), Positives = 95/255 (37%), Gaps = 64/255 (25%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDD 101
G FG ++ A +V VK ++ G + + E N+MK ++H L+K+ + +K+
Sbjct: 199 GQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 256
Query: 102 FKALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHI 134
+I E M GSL L + NYI + +I
Sbjct: 257 I-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315
Query: 135 MIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYNFGI 182
++ + + FG + ++++++ + I + AP D ++FGI
Sbjct: 316 LVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 183 MIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFV 242
++ME + +G + N P + + + R E C +
Sbjct: 374 LLMEIVT---------YGRIPYPGMSN---PEVIRALERGYRMPR-------PENCPEEL 414
Query: 243 FNLAMECTVESPNQR 257
+N+ M C P +R
Sbjct: 415 YNIMMRCWKNRPEER 429
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 36.2 bits (82), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 49/255 (19%), Positives = 95/255 (37%), Gaps = 64/255 (25%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDD 101
G FG ++ A +V VK ++ G + + E N+MK ++H L+K+ + +K+
Sbjct: 26 GQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 83
Query: 102 FKALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHI 134
+I E M GSL L + NYI + +I
Sbjct: 84 I-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 142
Query: 135 MIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAP------------DTYNFGI 182
++ + + FG + ++++++ + I + AP D ++FGI
Sbjct: 143 LVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 200
Query: 183 MIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFV 242
++ME + +G + N P + + + R E C +
Sbjct: 201 LLMEIVT---------YGRIPYPGMSN---PEVIRALERGYRMPR-------PENCPEEL 241
Query: 243 FNLAMECTVESPNQR 257
+N+ M C P +R
Sbjct: 242 YNIMMRCWKNRPEER 256
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 35.8 bits (81), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 99
I +G FG + + G +V VK ++ + E ++M +RH NL++++ +
Sbjct: 20 IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 100 DDFKALIL-ECMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH----- 152
+ I+ E M GSL L S +L L +DV A+EYL + H
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 136
Query: 153 --LLLKED-------------QSLTQIQTLATISYMAP------------DTYNFGIMIM 185
+L+ ED S TQ + + AP D ++FGI++
Sbjct: 137 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLW 196
Query: 186 ETFS-GKKP 193
E +S G+ P
Sbjct: 197 EIYSFGRVP 205
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 35.8 bits (81), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 99
I +G FG + + G +V VK ++ + E ++M +RH NL++++ +
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 100 DDFKALIL-ECMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH----- 152
+ I+ E M GSL L S +L L +DV A+EYL + H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 130
Query: 153 --LLLKED-------------QSLTQIQTLATISYMAP------------DTYNFGIMIM 185
+L+ ED S TQ + + AP D ++FGI++
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 186 ETFS-GKKP 193
E +S G+ P
Sbjct: 191 EIYSFGRVP 199
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 35.8 bits (81), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 38/158 (24%), Positives = 66/158 (41%), Gaps = 6/158 (3%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV VK + + + L E +MK++ H N++K+
Sbjct: 15 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L ++ + R + SAV+Y H H LK
Sbjct: 75 IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKFIVHRDLK 133
Query: 157 -EDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKP 193
E+ L + + + + FG ++TF G P
Sbjct: 134 AENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPP 170
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 35.8 bits (81), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 99
I +G FG + + G +V VK ++ + E ++M +RH NL++++ +
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 100 DDFKALIL-ECMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH----- 152
+ I+ E M GSL L S +L L +DV A+EYL + H
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145
Query: 153 --LLLKED-------------QSLTQIQTLATISYMAP------------DTYNFGIMIM 185
+L+ ED S TQ + + AP D ++FGI++
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 205
Query: 186 ETFS-GKKP 193
E +S G+ P
Sbjct: 206 EIYSFGRVP 214
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 35.8 bits (81), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 27 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 83
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 84 RYFFYSSGEKKDEVYLNLVLDYVPE 108
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 35.8 bits (81), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 35 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 91
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 92 RYFFYSSGEKKDEVYLNLVLDYVPE 116
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 35.4 bits (80), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPE 103
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 35.4 bits (80), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 23 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 79
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 80 RYFFYSSGEKKDEVYLNLVLDYVPE 104
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPE 103
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 41 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 97
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 98 RYFFYSSGEKKDEVYLNLVLDYVPE 122
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 30 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 86
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 87 RYFFYSSGEKKDEVYLNLVLDYVPE 111
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 50 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 106
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPE 131
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 112
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE 137
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDVVYLNLVLDYVPE 103
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 78
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPE 103
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 35.4 bits (80), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 90
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 91 RYFFYSSGEKKDEVYLNLVLDYVPE 115
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 35.4 bits (80), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 90
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 91 RYFFYSSGEKKDEVYLNLVLDYVPE 115
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 35.4 bits (80), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 34/161 (21%), Positives = 74/161 (45%), Gaps = 27/161 (16%)
Query: 33 LFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG-----AFKNLDVECNMMKIIRH 87
LFS+ I G FG++Y A+ EVV + Y G ++++ E ++ +RH
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS----AVE 143
N I+ ++ L++E CL +++ +L+ ++ +++A+ A++
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 144 YLHFGHSTHLLLKE---------DQSLTQIQTLATISYMAP 175
L + HS +++ ++ + L ++ + S MAP
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 112
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE 137
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 35.4 bits (80), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 58 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 114
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPE 139
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 35.4 bits (80), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 26 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 82
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 83 RYFFYSSGEKKDEVYLNLVLDYVPE 107
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 35.4 bits (80), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 60 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 116
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPE 141
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 35.4 bits (80), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 26/122 (21%), Positives = 49/122 (40%), Gaps = 4/122 (3%)
Query: 37 SNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 94
LI +G FG +Y + EV ++ +++ K E + RH+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 95 SSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLL 154
+C A+I +L + + +LD + I ++ + YLH H
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 155 LK 156
LK
Sbjct: 156 LK 157
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 35.0 bits (79), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 48/85 (56%), Gaps = 9/85 (10%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 93
++++ +I G FG +Y+AK+ D E+V LQ FKN +++ +M+ + H N++++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRL 157
Query: 94 ----ISSCSKDD--FKALILECMPH 112
SS K D + L+L+ +P
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPE 182
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 35.0 bits (79), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 99
I +G FG + + G +V VK ++ + E ++M +RH NL++++ +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 100 DDFKALIL-ECMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH----- 152
+ I+ E M GSL L S +L L +DV A+EYL + H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 317
Query: 153 --LLLKEDQ-------------SLTQIQTLATISYMAP------------DTYNFGIMIM 185
+L+ ED S TQ + + AP D ++FGI++
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 377
Query: 186 ETFS-GKKP 193
E +S G+ P
Sbjct: 378 EIYSFGRVP 386
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 35.0 bits (79), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 31/130 (23%), Positives = 59/130 (45%), Gaps = 7/130 (5%)
Query: 34 FSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGAF--KNLDVECNMMKII-RHQN 89
F E I G FGS++K K DG +K G+ +N E ++ +H +
Sbjct: 9 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 68
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLH 146
+++ S+ ++DD + E GSL +S + I+ +F+ +++ V + Y+H
Sbjct: 69 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 128
Query: 147 FGHSTHLLLK 156
H+ +K
Sbjct: 129 SMSLVHMDIK 138
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 35.0 bits (79), Expect = 0.043, Method: Compositional matrix adjust.
Identities = 31/130 (23%), Positives = 59/130 (45%), Gaps = 7/130 (5%)
Query: 34 FSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGAF--KNLDVECNMMKII-RHQN 89
F E I G FGS++K K DG +K G+ +N E ++ +H +
Sbjct: 11 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLH 146
+++ S+ ++DD + E GSL +S + I+ +F+ +++ V + Y+H
Sbjct: 71 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 147 FGHSTHLLLK 156
H+ +K
Sbjct: 131 SMSLVHMDIK 140
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 35.0 bits (79), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 31/130 (23%), Positives = 59/130 (45%), Gaps = 7/130 (5%)
Query: 34 FSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGAF--KNLDVECNMMKII-RHQN 89
F E I G FGS++K K DG +K G+ +N E ++ +H +
Sbjct: 11 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 70
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLH 146
+++ S+ ++DD + E GSL +S + I+ +F+ +++ V + Y+H
Sbjct: 71 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 130
Query: 147 FGHSTHLLLK 156
H+ +K
Sbjct: 131 SMSLVHMDIK 140
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 35.0 bits (79), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 31/54 (57%)
Query: 72 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI 125
++L E N++K + H ++IK+ +CS+D LI+E +GSL L S +
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 35.0 bits (79), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 31/54 (57%)
Query: 72 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI 125
++L E N++K + H ++IK+ +CS+D LI+E +GSL L S +
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 35.0 bits (79), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 31/54 (57%)
Query: 72 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI 125
++L E N++K + H ++IK+ +CS+D LI+E +GSL L S +
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 35.0 bits (79), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 31/130 (23%), Positives = 59/130 (45%), Gaps = 7/130 (5%)
Query: 34 FSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGAF--KNLDVECNMMKII-RHQN 89
F E I G FGS++K K DG +K G+ +N E ++ +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLH 146
+++ S+ ++DD + E GSL +S + I+ +F+ +++ V + Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 147 FGHSTHLLLK 156
H+ +K
Sbjct: 133 SMSLVHMDIK 142
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 34.7 bits (78), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 21/145 (14%)
Query: 31 LFLFSESNLISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQ 88
LF+F + G FG ++ + + G+E V+K N + ++ E ++K + H
Sbjct: 23 LFIFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 89 NLIKIISSCSKDDFKALILECMPHGSL----------GKCLSTSNYILDFFQRLHIMIDV 138
N+IKI +++E G L GK LS Y+ + +M +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS-EGYVAE------LMKQM 133
Query: 139 ASAVEYLHFGHSTHLLLKEDQSLTQ 163
+A+ Y H H H LK + L Q
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQ 158
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 34.7 bits (78), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 35/170 (20%), Positives = 71/170 (41%), Gaps = 32/170 (18%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 98
+ G FG ++ + +V VK L+ G + + E N+MK ++H L+++ + +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 99 KDDFKALILECMPHGSL---------GKCL------------------STSNYILDFFQR 131
K++ +I E M GSL GK L NYI +
Sbjct: 78 KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA 137
Query: 132 LHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFG 181
++++ + + FG + ++++++ + I + AP+ NFG
Sbjct: 138 ANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFG 185
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 34.7 bits (78), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 82
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 83 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 142 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 194
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 244
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 245 LCWKERPEDR 254
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 34.7 bits (78), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 25 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 83
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 84 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 142
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 143 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 195
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 196 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 245
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 246 LCWKERPEDR 255
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 34.7 bits (78), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 50/248 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 19 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 77
Query: 103 KALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHLLLK----- 156
+I E M +GSL L T + I L + L + +A + ++ + H L+
Sbjct: 78 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 136
Query: 157 ------------------EDQSLTQIQTLA-TISYMAPDTYNFGIMIMETFSGKKPTIKF 197
ED T + I + AP+ N+G TF+ K F
Sbjct: 137 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSF 191
Query: 198 --------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMEC 249
HG + N P + + + R D C ++ L C
Sbjct: 192 GILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMRLC 241
Query: 250 TVESPNQR 257
E P R
Sbjct: 242 WKERPEDR 249
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 4/130 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEV--VVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI 91
++ N I RG +G + K +Q G + K + E +MK + H N+I
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 151
++ + + L++E G L + + + IM DV SAV Y H +
Sbjct: 87 RLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNVA 145
Query: 152 HLLLKEDQSL 161
H LK + L
Sbjct: 146 HRDLKPENFL 155
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 34.3 bits (77), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 26 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 84
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 85 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 143
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 144 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 196
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 197 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 246
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 247 LCWKERPEDR 256
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 34.3 bits (77), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 33 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 91
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 92 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 150
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 151 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 203
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 204 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 253
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 254 LCWKERPEDR 263
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 34.3 bits (77), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 50/248 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 29 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 87
Query: 103 KALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHLLLK----- 156
+I E M +GSL L T + I L + L + +A + ++ + H L+
Sbjct: 88 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 146
Query: 157 ------------------EDQSLTQIQTLA-TISYMAPDTYNFGIMIMETFSGKKPTIKF 197
ED T + I + AP+ N+G TF+ K F
Sbjct: 147 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSF 201
Query: 198 --------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMEC 249
HG + N P + + + R D C ++ L C
Sbjct: 202 GILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMRLC 251
Query: 250 TVESPNQR 257
E P R
Sbjct: 252 WKERPEDR 259
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 34.3 bits (77), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 4/130 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEV--VVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI 91
++ N I RG +G + K +Q G + K + E +MK + H N+I
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 151
++ + + L++E G L + + + IM DV SAV Y H +
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128
Query: 152 HLLLKEDQSL 161
H LK + L
Sbjct: 129 HRDLKPENFL 138
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 34.3 bits (77), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 82
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 83 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 142 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 194
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 244
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 245 LCWKERPEDR 254
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 34.3 bits (77), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 32 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 90
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 91 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 149
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 150 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 202
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 203 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 252
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 253 LCWKERPEDR 262
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 34.3 bits (77), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 50/248 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 30 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 88
Query: 103 KALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHLLLK----- 156
+I E M +GSL L T + I L + L + +A + ++ + H L+
Sbjct: 89 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 157 ------------------EDQSLTQIQTLA-TISYMAPDTYNFGIMIMETFSGKKPTIKF 197
ED T + I + AP+ N+G TF+ K F
Sbjct: 148 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSF 202
Query: 198 --------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMEC 249
HG + N P + + + R D C ++ L C
Sbjct: 203 GILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMRLC 252
Query: 250 TVESPNQR 257
E P R
Sbjct: 253 WKERPEDR 260
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 34.3 bits (77), Expect = 0.074, Method: Compositional matrix adjust.
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 50/248 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 82
Query: 103 KALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHLLLK----- 156
+I E M +GSL L T + I L + L + +A + ++ + H L+
Sbjct: 83 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141
Query: 157 ------------------EDQSLTQIQTLA-TISYMAPDTYNFGIMIMETFSGKKPTIKF 197
ED T + I + AP+ N+G TF+ K F
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSF 196
Query: 198 --------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMEC 249
HG + N P + + + R D C ++ L C
Sbjct: 197 GILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMRLC 246
Query: 250 TVESPNQR 257
E P R
Sbjct: 247 WKERPEDR 254
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 34.3 bits (77), Expect = 0.076, Method: Compositional matrix adjust.
Identities = 50/250 (20%), Positives = 89/250 (35%), Gaps = 54/250 (21%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 30 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 88
Query: 103 KALILECMPHGSLGKCLSTS---------------------------NYILDFFQRLHIM 135
+I E M +GSL L T NYI + +I+
Sbjct: 89 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 147
Query: 136 IDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKPTI 195
+ + + FG + L+++++ + I + AP+ N+G TF+ K
Sbjct: 148 VSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEAINYG-----TFTIKSDVW 200
Query: 196 KF--------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAM 247
F HG + N P + + + R D C ++ L
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMR 250
Query: 248 ECTVESPNQR 257
C E P R
Sbjct: 251 LCWKERPEDR 260
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 34.3 bits (77), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 50/248 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 34 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 92
Query: 103 KALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHLLLK----- 156
+I E M +GSL L T + I L + L + +A + ++ + H L+
Sbjct: 93 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 151
Query: 157 ------------------EDQSLTQIQTLA-TISYMAPDTYNFGIMIMETFSGKKPTIKF 197
ED T + I + AP+ N+G TF+ K F
Sbjct: 152 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSF 206
Query: 198 --------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMEC 249
HG + N P + + + R D C ++ L C
Sbjct: 207 GILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMRLC 256
Query: 250 TVESPNQR 257
E P R
Sbjct: 257 WKERPEDR 264
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 34.3 bits (77), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 50/248 (20%)
Query: 43 GGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF 102
G FG ++ +V VK Q + E N+MK ++HQ L+++ + +++
Sbjct: 20 GQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI 78
Query: 103 KALILECMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHLLLK----- 156
+I E M +GSL L T + I L + L + +A + ++ + H L+
Sbjct: 79 -YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANIL 137
Query: 157 ------------------EDQSLTQIQTLA-TISYMAPDTYNFGIMIMETFSGKKPTIKF 197
ED T + I + AP+ N+G TF+ K F
Sbjct: 138 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-----TFTIKSDVWSF 192
Query: 198 --------FHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMEC 249
HG + N P + + + R D C ++ L C
Sbjct: 193 GILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPD-------NCPEELYQLMRLC 242
Query: 250 TVESPNQR 257
E P R
Sbjct: 243 WKERPEDR 250
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 33.9 bits (76), Expect = 0.086, Method: Compositional matrix adjust.
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 56/260 (21%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A ++ G V VK +L+ + L E +M+ +H+N++++ +S
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + G+L ++ + ++ Q + + V A+ LH H +K D
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 145
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L Q+ + T +MAP D ++ GIM
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 205
Query: 184 IMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVF 243
++E G+ P + E LK MK++ NL R F+
Sbjct: 206 VIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSLKGFLD 251
Query: 244 NLAMECTVESPNQRINAKEM 263
L V P QR A E+
Sbjct: 252 RL----LVRDPAQRATAAEL 267
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 33.9 bits (76), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 56/260 (21%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A ++ G V VK +L+ + L E +M+ +H+N++++ +S
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + G+L ++ + ++ Q + + V A+ LH H +K D
Sbjct: 92 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 149
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L Q+ + T +MAP D ++ GIM
Sbjct: 150 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 209
Query: 184 IMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVF 243
++E G+ P + E LK MK++ NL R F+
Sbjct: 210 VIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSLKGFLD 255
Query: 244 NLAMECTVESPNQRINAKEM 263
L V P QR A E+
Sbjct: 256 RL----LVRDPAQRATAAEL 271
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 33.9 bits (76), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 52/243 (21%), Positives = 94/243 (38%), Gaps = 55/243 (22%)
Query: 56 GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL 115
G +V VK +L+ + L E +M+ H N++ + SS D +++E + G+L
Sbjct: 70 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 116 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSL-------------- 161
++ + ++ Q + + V A+ YLH H +K D L
Sbjct: 130 TDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGF 187
Query: 162 -TQIQT--------LATISYMAP------------DTYNFGIMIMETFSGKKPTIKFFHG 200
Q+ + T +MAP D ++ GIM++E G+ P F
Sbjct: 188 CAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY--FNEP 245
Query: 201 EMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQRINA 260
+ + D LP V +D H ++ + +L + V P+QR A
Sbjct: 246 PLQAMRRIRDSLPPRV-----------KDLHKVSS--VLRGFLDLML---VREPSQRATA 289
Query: 261 KEM 263
+E+
Sbjct: 290 QEL 292
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 33.9 bits (76), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 61 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 119 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 33.9 bits (76), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 34/171 (19%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 98
+ G FG ++ + +V VK L+ G + + E N+MK ++H L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 99 KDDFKALILECMPHGSL---------GKCL------------------STSNYILDFFQR 131
+++ +I E M GSL GK L NYI +
Sbjct: 79 REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRA 138
Query: 132 LHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLA-TISYMAPDTYNFG 181
++++ + + FG + + ED T + I + AP+ NFG
Sbjct: 139 ANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFG 186
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 33.9 bits (76), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 8/168 (4%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV VK + + + L E +MK++ H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L + + R + SAV+Y H H LK
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIVHRDLK 140
Query: 157 -EDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKP--TIKFFHGE 201
E+ L + + + + FG ++TF G P + F G+
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGK 187
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 56/260 (21%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A ++ G V VK +L+ + L E +M+ +H+N++++ +S
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + G+L ++ + ++ Q + + V A+ LH H +K D
Sbjct: 97 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 154
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L Q+ + T +MAP D ++ GIM
Sbjct: 155 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 214
Query: 184 IMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVF 243
++E G+ P + E LK MK++ NL R F+
Sbjct: 215 VIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSLKGFLD 260
Query: 244 NLAMECTVESPNQRINAKEM 263
L V P QR A E+
Sbjct: 261 RL----LVRDPAQRATAAEL 276
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 8/168 (4%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV VK + + + L E +MK++ H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L + + R + SAV+Y H H LK
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIVHRDLK 140
Query: 157 -EDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKP--TIKFFHGE 201
E+ L + + + + FG ++TF G P + F G+
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGK 187
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 55 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 112
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 113 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 56/260 (21%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A ++ G V VK +L+ + L E +M+ +H+N++++ +S
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + G+L ++ + ++ Q + + V A+ LH H +K D
Sbjct: 99 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 156
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L Q+ + T +MAP D ++ GIM
Sbjct: 157 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 216
Query: 184 IMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVF 243
++E G+ P + E LK MK++ NL R F+
Sbjct: 217 VIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSLKGFLD 262
Query: 244 NLAMECTVESPNQRINAKEM 263
L V P QR A E+
Sbjct: 263 RL----LVRDPAQRATAAEL 278
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 57 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 114
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 67 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 124
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 53/274 (19%), Positives = 91/274 (33%), Gaps = 74/274 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK Y LD +E ++ HQN++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQ-DELDFLMEALIISKFNHQNIV 111
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 146 HFGHSTHLLLKEDQSLTQIQ----------------------------TLATISYMAP-- 175
H H + L + + +M P
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
DT++FG+++ E FS G M N V++ V++
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSN----QEVLEFVTSG-- 276
Query: 226 SREDEHFMTKEQCMSFVFNLAMECTVESPNQRIN 259
R D + C V+ + +C P R N
Sbjct: 277 GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPN 306
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 61 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 119 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 75 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 132
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 133 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 77 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 135 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 77 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 135 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 33.1 bits (74), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 20 SLDLSNNN--FSGLFLFSESNLISRGGFGSIYKAKIQD-GMEVVVKGF-NLQYGGAFKNL 75
+DL N F + + L+ G +G + K + +D G V +K F K +
Sbjct: 11 GVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI 70
Query: 76 DV-ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPH 112
+ E ++K +RH+NL+ ++ C K L+ E + H
Sbjct: 71 AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 4/125 (3%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ + G EV VK + + + L E +MKI+ H N++K+
Sbjct: 23 IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L + + R + SAV+Y H + H LK
Sbjct: 83 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKYIVHRDLK 141
Query: 157 EDQSL 161
+ L
Sbjct: 142 AENLL 146
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 33.1 bits (74), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 477 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 32.7 bits (73), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 32/156 (20%), Positives = 62/156 (39%), Gaps = 41/156 (26%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
E N+M+ + + ++++I C + + L++E G L K L + ++ D + ++
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 137 DVASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATI 170
V+ ++YL FG S L E+ Q +
Sbjct: 478 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 171 SYMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E FS G+KP
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 32.7 bits (73), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 56/260 (21%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A ++ G V VK +L+ + L E +M+ +H+N++++ +S
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + G+L ++ + ++ Q + + V A+ LH H +K D
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 199
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L Q+ + T +MAP D ++ GIM
Sbjct: 200 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 259
Query: 184 IMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVF 243
++E G+ P + E LK MK++ NL R F+
Sbjct: 260 VIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSLKGFLD 305
Query: 244 NLAMECTVESPNQRINAKEM 263
L V P QR A E+
Sbjct: 306 RL----LVRDPAQRATAAEL 321
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 32.7 bits (73), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 26/132 (19%), Positives = 59/132 (44%), Gaps = 1/132 (0%)
Query: 31 LFLFSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 89
+ S++ ++ G FG ++K + G+++ K + + + E ++M + H N
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 149
LI++ + + L++E + G L + +Y L + M + + ++H +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207
Query: 150 STHLLLKEDQSL 161
HL LK + L
Sbjct: 208 ILHLDLKPENIL 219
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 32.7 bits (73), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 8/168 (4%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV V+ + + + L E +MK++ H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L + + R + SAV+Y H H LK
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIVHRDLK 140
Query: 157 -EDQSLTQIQTLATISYMAPDTYNFGIMIMETFSGKKP--TIKFFHGE 201
E+ L + + + + FG ++TF G P + F G+
Sbjct: 141 AENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGK 187
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 39/155 (25%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMID 137
E ++M H N+I++ ++ ++ E M +GSL L T + Q + ++
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 138 VASAVEYLH--------------------------FGHSTHLLLKEDQSLTQIQTLATIS 171
V + + YL FG S L D + T I
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIR 219
Query: 172 YMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E + G++P
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 32.7 bits (73), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 39/155 (25%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMID 137
E ++M H N+I++ ++ ++ E M +GSL L T + Q + ++
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 138 VASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTLATIS 171
V + + YL FG S L D + T I
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 172 YMAP------------DTYNFGIMIMETFS-GKKP 193
+ AP D ++FG+++ E + G++P
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
>pdb|3ZHP|A Chain A, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|B Chain B, Human Mst3 (stk24) In Complex With Mo25beta
Length = 340
Score = 32.3 bits (72), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 32/131 (24%), Positives = 53/131 (40%), Gaps = 36/131 (27%)
Query: 105 LILECMPHGSLGKCLSTSNYILDFFQRLHI-MIDVAS----------------AVEYLHF 147
++ EC+ H L K + SN DFF+ + + D+AS ++L
Sbjct: 148 MLRECIRHEPLAKIILFSNQFRDFFKYVELSTFDIASDAFATFKDLLTRHKVLVADFLEQ 207
Query: 148 GHST-----HLLLKEDQSLTQIQTLATISYMAPDTYNFGIM------------IMETFSG 190
+ T LL+ + +T+ Q+L + + D +NF IM +M
Sbjct: 208 NYDTIFEDYEKLLQSENYVTKRQSLKLLGELILDRHNFAIMTKYISKPENLKLMMNLLRD 267
Query: 191 KKPTIKF--FH 199
K P I+F FH
Sbjct: 268 KSPNIQFEAFH 278
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 52/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ + HQN++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 98 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 146 HFGHSTH 152
H H
Sbjct: 158 EENHFIH 164
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 32.3 bits (72), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 14/138 (10%)
Query: 44 GFGSIYKAKIQD----GMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIKI 93
G G+ K KI + G +V VK N Q ++LDV E +K+ RH ++IK+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHL 153
S +++E + G L + + + R + + SAV+Y H H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMVVHR 135
Query: 154 LLKEDQSLTQIQTLATIS 171
LK + L A I+
Sbjct: 136 DLKPENVLLDAHMNAKIA 153
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 32.3 bits (72), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 14/138 (10%)
Query: 44 GFGSIYKAKIQD----GMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIKI 93
G G+ K KI + G +V VK N Q ++LDV E +K+ RH ++IK+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHL 153
S +++E + G L + + + R + + SAV+Y H H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMVVHR 135
Query: 154 LLKEDQSLTQIQTLATIS 171
LK + L A I+
Sbjct: 136 DLKPENVLLDAHMNAKIA 153
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 32.3 bits (72), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 52/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ + HQN++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 146 HFGHSTH 152
H H
Sbjct: 172 EENHFIH 178
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 32.3 bits (72), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 31/125 (24%), Positives = 52/125 (41%), Gaps = 4/125 (3%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV VK + + + L E +MK++ H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L + + R + SAV+Y H H LK
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIVHRDLK 140
Query: 157 EDQSL 161
+ L
Sbjct: 141 AENLL 145
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 56/260 (21%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A ++ G V VK +L+ + L E +M+ +H+N++++ +S
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
D +++E + G+L ++ + ++ Q + + V A+ LH H +K D
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L Q+ + T +MAP D ++ GIM
Sbjct: 277 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 336
Query: 184 IMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHFMTKEQCMSFVF 243
++E G+ P + E LK MK++ NL R F+
Sbjct: 337 VIEMVDGEPP----YFNEPPLK----------AMKMIRDNLPPRLKNLHKVSPSLKGFLD 382
Query: 244 NLAMECTVESPNQRINAKEM 263
L V P QR A E+
Sbjct: 383 RL----LVRDPAQRATAAEL 398
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 32.0 bits (71), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 44/194 (22%), Positives = 76/194 (39%), Gaps = 44/194 (22%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 98
+ +G FG ++ V +K L+ G + + E +MK +RH+ L+++ + S
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 99 KDDFKALILECMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
++ ++ E M GSL L T Y L Q + + +AS + Y+ + H L+
Sbjct: 74 EEPI-XIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYVHRDLR 131
Query: 157 -----------------------EDQSLTQIQTLA-TISYMAP------------DTYNF 180
ED T Q I + AP D ++F
Sbjct: 132 AANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 191
Query: 181 GIMIME-TFSGKKP 193
GI++ E T G+ P
Sbjct: 192 GILLTELTTKGRVP 205
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 32.0 bits (71), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 4/125 (3%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV +K + + + L E +MKI+ H N++K+
Sbjct: 20 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ LI+E G + L + + R + SAV+Y H H LK
Sbjct: 80 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQKRIVHRDLK 138
Query: 157 EDQSL 161
+ L
Sbjct: 139 AENLL 143
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 32.0 bits (71), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 45/214 (21%), Positives = 77/214 (35%), Gaps = 49/214 (22%)
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYI-LDFFQRLHIM 135
E N+MK ++HQ L+++ + +++ +I E M +GSL L T + I L + L +
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 136 IDVASAVEYLHFGHSTHLLLK-----------------------EDQSLTQIQTLA-TIS 171
+A + ++ + H L+ ED T + I
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK 175
Query: 172 YMAPDTYNFGIMIMETFSGKKPTIKF--------FHGEMTLKHWVNDLLPNSVMKVVSAN 223
+ AP+ N+G TF+ K F HG + N P + +
Sbjct: 176 WTAPEAINYG-----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGY 227
Query: 224 LLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
+ R D C ++ L C E P R
Sbjct: 228 RMVRPD-------NCPEELYQLMRLCWKERPEDR 254
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 32.0 bits (71), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 146 HFGHSTH 152
H H
Sbjct: 174 EENHFIH 180
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 32.0 bits (71), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 146 HFGHSTH 152
H H
Sbjct: 184 EENHFIH 190
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 32.0 bits (71), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 4/125 (3%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV +K + + + L E +MKI+ H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ LI+E G + L + + R + SAV+Y H H LK
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQKRIVHRDLK 141
Query: 157 EDQSL 161
+ L
Sbjct: 142 AENLL 146
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 31.6 bits (70), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 98 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 146 HFGHSTH 152
H H
Sbjct: 158 EENHFIH 164
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 98 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 146 HFGHSTH 152
H H
Sbjct: 158 EENHFIH 164
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 146 HFGHSTH 152
H H
Sbjct: 198 EENHFIH 204
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 31.6 bits (70), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 29/127 (22%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 146 HFGHSTH 152
H H
Sbjct: 164 EENHFIH 170
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 31.6 bits (70), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 52/274 (18%), Positives = 91/274 (33%), Gaps = 74/274 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 97 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 146 HFGHSTHLLLKEDQSLTQIQ----------------------------TLATISYMAP-- 175
H H + L + + +M P
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
DT++FG+++ E FS G M N V++ V++
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSN----QEVLEFVTSG-- 261
Query: 226 SREDEHFMTKEQCMSFVFNLAMECTVESPNQRIN 259
R D + C V+ + +C P R N
Sbjct: 262 GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPN 291
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 31.6 bits (70), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 52/274 (18%), Positives = 91/274 (33%), Gaps = 74/274 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 89 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 146 HFGHSTHLLLKEDQSLTQIQ----------------------------TLATISYMAP-- 175
H H + L + + +M P
Sbjct: 149 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 208
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
DT++FG+++ E FS G M N V++ V++
Sbjct: 209 FMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSN----QEVLEFVTSG-- 253
Query: 226 SREDEHFMTKEQCMSFVFNLAMECTVESPNQRIN 259
R D + C V+ + +C P R N
Sbjct: 254 GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPN 283
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 31.6 bits (70), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 52/274 (18%), Positives = 91/274 (33%), Gaps = 74/274 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + ++LE M G L L + L LH+ D+A +YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 146 HFGHSTHLLLKEDQSLTQIQ----------------------------TLATISYMAP-- 175
H H + L + + +M P
Sbjct: 175 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 234
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
DT++FG+++ E FS G M N V++ V++
Sbjct: 235 FMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSN----QEVLEFVTSG-- 279
Query: 226 SREDEHFMTKEQCMSFVFNLAMECTVESPNQRIN 259
R D + C V+ + +C P R N
Sbjct: 280 GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPN 309
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 31.6 bits (70), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 36/136 (26%), Positives = 57/136 (41%), Gaps = 11/136 (8%)
Query: 43 GGFGSIYKAKIQ-DGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIKIIS 95
G FG + K + G +V VK N Q ++LDV E +K+ RH ++IK+
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 96 SCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLL 155
S +++E + G L + N LD + + + S V+Y H H L
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 156 KEDQSLTQIQTLATIS 171
K + L A I+
Sbjct: 143 KPENVLLDAHMNAKIA 158
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 31.6 bits (70), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 26/111 (23%), Positives = 52/111 (46%), Gaps = 9/111 (8%)
Query: 20 SLDLSNNN--FSGLF-LFSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGA--FK 73
+DL N F ++ LF E + +G F + + K+ G E K N + A +
Sbjct: 10 GVDLGTENLYFQSMYQLFEE---LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ 66
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNY 124
L+ E + ++++H N++++ S S++ LI + + G L + + Y
Sbjct: 67 KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 117
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 31.2 bits (69), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 30/125 (24%), Positives = 52/125 (41%), Gaps = 4/125 (3%)
Query: 40 ISRGGFGSIYKAK-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + A+ I G EV V+ + + + L E +MK++ H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLK 156
+ L++E G + L + + R + SAV+Y H H LK
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIVHRDLK 140
Query: 157 EDQSL 161
+ L
Sbjct: 141 AENLL 145
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 31.2 bits (69), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 19/79 (24%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 40 ISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISS 96
I +G F + + K+ G E K N + A + L+ E + ++++H N++++ S
Sbjct: 12 IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 97 CSKDDFKALILECMPHGSL 115
S++ F L+ + + G L
Sbjct: 72 ISEEGFHYLVFDLVTGGEL 90
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 31.2 bits (69), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 50/208 (24%), Positives = 79/208 (37%), Gaps = 59/208 (28%)
Query: 33 LFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 92
LF++ I +G FG ++K I + + VV A K +D+E +I Q I
Sbjct: 23 LFTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEIT 72
Query: 93 IISSCS------------KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 140
++S C KD +I+E + GS L LD Q I+ ++
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK 130
Query: 141 AVEYLHFGHSTH-------LLLKEDQSL-------------TQIQT---LATISYMAP-- 175
++YLH H +LL E + TQI+ + T +MAP
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 190
Query: 176 ----------DTYNFGIMIMETFSGKKP 193
D ++ GI +E G+ P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 31.2 bits (69), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 62/203 (30%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 98
+ +G FG ++ V +K L+ G + + E +MK +RH+ L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASA-------VEY 144
++ +++E M GSL LDF + RL ++D+A+ VE
Sbjct: 84 EEPI-YIVIEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 145 LHFGH----STHLL----------------LKEDQSLTQIQTLA-TISYMAP-------- 175
+++ H + ++L L ED T Q I + AP
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 192
Query: 176 ----DTYNFGIMIME-TFSGKKP 193
D ++FGI++ E T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 31.2 bits (69), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 50/208 (24%), Positives = 79/208 (37%), Gaps = 59/208 (28%)
Query: 33 LFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 92
LF++ I +G FG ++K I + + VV A K +D+E +I Q I
Sbjct: 8 LFTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEIT 57
Query: 93 IISSCS------------KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 140
++S C KD +I+E + GS L LD Q I+ ++
Sbjct: 58 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK 115
Query: 141 AVEYLHFGHSTH-------LLLKEDQSL-------------TQIQT---LATISYMAP-- 175
++YLH H +LL E + TQI+ + T +MAP
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 176 ----------DTYNFGIMIMETFSGKKP 193
D ++ GI +E G+ P
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPP 203
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 31.2 bits (69), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 50/208 (24%), Positives = 79/208 (37%), Gaps = 59/208 (28%)
Query: 33 LFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 92
LF++ I +G FG ++K I + + VV A K +D+E +I Q I
Sbjct: 8 LFTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEIT 57
Query: 93 IISSCS------------KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 140
++S C KD +I+E + GS L LD Q I+ ++
Sbjct: 58 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK 115
Query: 141 AVEYLHFGHSTH-------LLLKEDQSL-------------TQIQT---LATISYMAP-- 175
++YLH H +LL E + TQI+ + T +MAP
Sbjct: 116 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 176 ----------DTYNFGIMIMETFSGKKP 193
D ++ GI +E G+ P
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPP 203
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 31.2 bits (69), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 50/208 (24%), Positives = 79/208 (37%), Gaps = 59/208 (28%)
Query: 33 LFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 92
LF++ I +G FG ++K I + + VV A K +D+E +I Q I
Sbjct: 28 LFTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEIT 77
Query: 93 IISSCS------------KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 140
++S C KD +I+E + GS L LD Q I+ ++
Sbjct: 78 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK 135
Query: 141 AVEYLHFGHSTH-------LLLKEDQSL-------------TQIQT---LATISYMAP-- 175
++YLH H +LL E + TQI+ + T +MAP
Sbjct: 136 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 195
Query: 176 ----------DTYNFGIMIMETFSGKKP 193
D ++ GI +E G+ P
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGEPP 223
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 31.2 bits (69), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 62/203 (30%)
Query: 40 ISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 98
+ +G FG ++ V +K L+ G + + E +MK +RH+ L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASA-------VEY 144
++ +++E M GSL LDF + RL ++D+A+ VE
Sbjct: 84 EEPI-YIVIEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 145 LHFGH----STHLL----------------LKEDQSLTQIQTLA-TISYMAP-------- 175
+++ H + ++L L ED T Q I + AP
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 176 ----DTYNFGIMIME-TFSGKKP 193
D ++FGI++ E T G+ P
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVP 215
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 31.2 bits (69), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
+N+I ++ +C++D +I+E G+L + L
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 31.2 bits (69), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
+N+I ++ +C++D +I+E G+L + L
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 30.8 bits (68), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
+N+I ++ +C++D +I+E G+L + L
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 30.8 bits (68), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
+N+I ++ +C++D +I+E G+L + L
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 30.8 bits (68), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
+N+I ++ +C++D +I+E G+L + L
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 30.8 bits (68), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 56 GMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSCSKDDFKA--LILECMPH 112
G V VK G ++ E ++++ + H+++IK C K+ L++E +P
Sbjct: 43 GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 113 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 152
GSL L + + Q L + + YLH H H
Sbjct: 103 GSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIH 140
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 30.8 bits (68), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 51/274 (18%), Positives = 91/274 (33%), Gaps = 74/274 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + +++E M G L L + L LH+ D+A +YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 146 HFGHSTHLLLKEDQSLTQIQ----------------------------TLATISYMAP-- 175
H H + L + + +M P
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
DT++FG+++ E FS G M N V++ V++
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSN----QEVLEFVTSG-- 261
Query: 226 SREDEHFMTKEQCMSFVFNLAMECTVESPNQRIN 259
R D + C V+ + +C P R N
Sbjct: 262 GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPN 291
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 30.8 bits (68), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 49/218 (22%), Positives = 80/218 (36%), Gaps = 59/218 (27%)
Query: 23 LSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMM 82
+ NN LF++ I +G FG ++K +VV A K +D+E
Sbjct: 14 MQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLEEAED 63
Query: 83 KIIRHQNLIKIISSCS------------KDDFKALILECMPHGSLGKCLSTSNYILDFFQ 130
+I Q I ++S C K +I+E + GS L + D FQ
Sbjct: 64 EIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQ 121
Query: 131 RLHIMIDVASAVEYLHFGHSTH-------LLLKEDQSL-------------TQIQT---L 167
++ ++ ++YLH H +LL E + TQI+ +
Sbjct: 122 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 181
Query: 168 ATISYMAP------------DTYNFGIMIMETFSGKKP 193
T +MAP D ++ GI +E G+ P
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 30.8 bits (68), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 30.8 bits (68), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 51/274 (18%), Positives = 91/274 (33%), Gaps = 74/274 (27%)
Query: 40 ISRGGFGSIYKAKI------QDGMEVVVKGFNLQYGGAFKNLD--VECNMMKIIRHQNLI 91
+ G FG +Y+ ++ ++V VK + LD +E ++ HQN++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 92 KIISSCSKDDFKALILECMPHGSLGKCL------STSNYILDFFQRLHIMIDVASAVEYL 145
+ I + + +++E M G L L + L LH+ D+A +YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 146 HFGHSTHLLLKEDQSLTQIQ----------------------------TLATISYMAP-- 175
H H + L + + +M P
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
DT++FG+++ E FS G M N V++ V++
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS---------LGYMPYPSKSN----QEVLEFVTSG-- 276
Query: 226 SREDEHFMTKEQCMSFVFNLAMECTVESPNQRIN 259
R D + C V+ + +C P R N
Sbjct: 277 GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPN 306
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 30.8 bits (68), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 14/94 (14%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+N+I ++ +C++D +I+E G+L + L
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRA 134
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 30.8 bits (68), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 30.4 bits (67), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 56 GMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSCSKDDFKA--LILECMPH 112
G V VK G ++ E ++++ + H+++IK C K+ L++E +P
Sbjct: 43 GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 113 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 152
GSL L + + Q L + + YLH H H
Sbjct: 103 GSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQHYIH 140
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 30.4 bits (67), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 27/126 (21%), Positives = 57/126 (45%), Gaps = 4/126 (3%)
Query: 43 GGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD 101
G FG +YKAK ++ G K + ++ VE ++ H ++K++ + D
Sbjct: 30 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89
Query: 102 FKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSL 161
+++E P G++ + + L Q I + +E L+F HS ++ ++ ++
Sbjct: 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDLKAG 146
Query: 162 TQIQTL 167
+ TL
Sbjct: 147 NVLMTL 152
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 30.4 bits (67), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 27/126 (21%), Positives = 57/126 (45%), Gaps = 4/126 (3%)
Query: 43 GGFGSIYKAKIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD 101
G FG +YKAK ++ G K + ++ VE ++ H ++K++ + D
Sbjct: 22 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 81
Query: 102 FKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSL 161
+++E P G++ + + L Q I + +E L+F HS ++ ++ ++
Sbjct: 82 KLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDLKAG 138
Query: 162 TQIQTL 167
+ TL
Sbjct: 139 NVLMTL 144
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 30.4 bits (67), Expect = 0.97, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 11 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 62
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 63 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 228
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 229 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 265
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 30.4 bits (67), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 168
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 28 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 79
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 80 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 139
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 200 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 245
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 246 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 282
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 10/90 (11%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGA-FKNLDVECNMMKII-RHQN 89
+ G FG + K K ++ + V VK +L E MMK+I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCL 119
+I ++ +C++D +I+E G+L + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 28/132 (21%), Positives = 56/132 (42%), Gaps = 13/132 (9%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL 145
++ +AS ++YL
Sbjct: 152 MLRGIASGMKYL 163
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 38 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 89
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 90 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 149
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 210 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 255
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 256 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 292
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 257
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 258 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
>pdb|2H9A|B Chain B, Corrinoid Iron-Sulfur Protein
pdb|2YCL|B Chain B, Complete Structure Of The Corrinoid,Iron-Sulfur Protein
Including The N-Terminal Domain With A 4fe-4s Cluster
Length = 310
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 13/44 (29%), Positives = 29/44 (65%), Gaps = 2/44 (4%)
Query: 93 IISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
++SS +KD++K ++ CM HG ++++ ++ ++L+IMI
Sbjct: 153 LLSSATKDNYKPIVATCMVHGH--SVVASAPLDINLSKQLNIMI 194
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 52/283 (18%), Positives = 101/283 (35%), Gaps = 72/283 (25%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 11 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 62
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 63 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 134 IMIDVASAVEYL--------------------------HFGHSTHLLLKEDQSLTQIQTL 167
++ +AS ++YL FG S L + + T
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 168 ATISYMAP------------DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPN 214
I + +P D +++GI++ E S G++P +W ++
Sbjct: 183 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP------------YW--EMSNQ 228
Query: 215 SVMKVVSANLLSREDEHFMTKEQCMSFVFNLAMECTVESPNQR 257
V+K V E C + ++ L ++C + N R
Sbjct: 229 DVIKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 265
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 28/132 (21%), Positives = 56/132 (42%), Gaps = 13/132 (9%)
Query: 19 KSLDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQ----DGMEVVVKGFNLQYG-GAFK 73
K LD +N S ++ G FG + +++ + V +K + Y +
Sbjct: 40 KELDATN--------ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
+ E ++M H N+I++ +K ++ E M +GSL L + Q +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 134 IMIDVASAVEYL 145
++ +AS ++YL
Sbjct: 152 MLRGIASGMKYL 163
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 102
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 1/92 (1%)
Query: 67 QYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYIL 126
+ G + + ++ E N+++ IRH N+I + LILE + G L L+ +
Sbjct: 68 RRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT 127
Query: 127 DFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
+ + + + V YLH H LK +
Sbjct: 128 E-DEATQFLKQILDGVHYLHSKRIAHFDLKPE 158
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 15/30 (50%), Positives = 19/30 (63%), Gaps = 1/30 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQ-DGMEVVVK 62
F E LI GGFG ++KAK + DG V+K
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIK 42
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 1/92 (1%)
Query: 67 QYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYIL 126
+ G + + ++ E N+++ IRH N+I + LILE + G L L+ +
Sbjct: 54 RRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT 113
Query: 127 DFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
+ + + + V YLH H LK +
Sbjct: 114 E-DEATQFLKQILDGVHYLHSKRIAHFDLKPE 144
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 69 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 99
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 94
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 3/124 (2%)
Query: 40 ISRGGFGSIYKA-KIQDGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSC 97
I GGF + A I G V +K + G + E +K +RHQ++ ++
Sbjct: 18 IGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVL 77
Query: 98 SKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKE 157
+ ++LE P G L + + + + + R+ + + SAV Y+H H LK
Sbjct: 78 ETANKIFMVLEYCPGGELFDYIISQDRLSEEETRV-VFRQIVSAVAYVHSQGYAHRDLKP 136
Query: 158 DQSL 161
+ L
Sbjct: 137 ENLL 140
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 94
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 83 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 83 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 1/92 (1%)
Query: 67 QYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYIL 126
+ G + + ++ E N+++ IRH N+I + LILE + G L L+ +
Sbjct: 47 RRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT 106
Query: 127 DFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
+ + + + V YLH H LK +
Sbjct: 107 E-DEATQFLKQILDGVHYLHSKRIAHFDLKPE 137
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 75 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 119
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 72 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 116
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 6/76 (7%)
Query: 48 IYKAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RHQNLIKIISSCSKDDFK 103
I K K ++ + V VK L+ K+L E MMK+I +H+N+I ++ +C++D
Sbjct: 105 IDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162
Query: 104 ALILECMPHGSLGKCL 119
+I+E G+L + L
Sbjct: 163 YVIVEYASKGNLREYL 178
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 76 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 120
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 94
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 94
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 96
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 97
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 96
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 97
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 82 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 96
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 98
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 97
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 102
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 77 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 29.6 bits (65), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 96
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 25/129 (19%), Positives = 55/129 (42%), Gaps = 1/129 (0%)
Query: 43 GGFGSIYK-AKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD 101
G FG +++ + G V K N Y + E ++M + H LI + +
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 102 FKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSL 161
LILE + G L ++ +Y + + ++ M ++++H HL +K + +
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 162 TQIQTLATI 170
+ + +++
Sbjct: 182 CETKKASSV 190
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 79 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 83 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 29.6 bits (65), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 83 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 127
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 69 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 99
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 29.6 bits (65), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 98
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/92 (23%), Positives = 42/92 (45%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKG---FNLQYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV + + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 95
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 22/92 (23%), Positives = 42/92 (45%), Gaps = 4/92 (4%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVVVKG---FNLQYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV + + G E +++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 91 IKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
+K++ ++ L+ E + H L K + S
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS 94
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 33/147 (22%), Positives = 67/147 (45%), Gaps = 6/147 (4%)
Query: 20 SLDLSNNNFSGLFLFSESNLISRGGFGSIYKA-KIQDGMEVVVKGFNLQYGGAFKNL--D 76
S D F ++ + S L+ G + + A +Q+G E VK Q G + + +
Sbjct: 2 STDSLPGKFEDMYKLT-SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFRE 60
Query: 77 VECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMI 136
VE + + ++N++++I D L+ E + GS+ + + + + ++
Sbjct: 61 VE-TLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVR 118
Query: 137 DVASAVEYLHFGHSTHLLLKEDQSLTQ 163
DVA+A+++LH H LK + L +
Sbjct: 119 DVAAALDFLHTKGIAHRDLKPENILCE 145
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 12/124 (9%)
Query: 37 SNLISRGGFGSIYKA--------KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ 88
+ ++ G FG +Y+ KI ++ K L F + E +MK + H
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDHP 69
Query: 89 NLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 148
+++K+I ++ +I+E P+G LG L + L + + + A+ YL
Sbjct: 70 HIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 149 HSTH 152
+ H
Sbjct: 129 NCVH 132
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 28/45 (62%), Gaps = 1/45 (2%)
Query: 78 ECNMMKII-RHQNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
E MMK+I +H+N+I ++ +C++D +I+E G+L + L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 112
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 29.6 bits (65), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 26/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 56 GMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHG 113
G+E K N + A F+ L+ E + + ++H N++++ S ++ F L+ + + G
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 114 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYM 173
L + + + + H + + ++ Y H H LK + L + +
Sbjct: 114 ELFEDIVAREFYSE-ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 172
Query: 174 APDTYNFGIMI 184
A +FG+ I
Sbjct: 173 A----DFGLAI 179
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 245 FYQML-------LAVQYLHENGIIHRDLKPENVLLSSQ 275
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 12/124 (9%)
Query: 37 SNLISRGGFGSIYKA--------KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ 88
+ ++ G FG +Y+ KI ++ K L F + E +MK + H
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDHP 85
Query: 89 NLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 148
+++K+I ++ +I+E P+G LG L + L + + + A+ YL
Sbjct: 86 HIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 149 HSTH 152
+ H
Sbjct: 145 NCVH 148
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 19/30 (63%), Gaps = 1/30 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQ-DGMEVVVK 62
F E LI GGFG ++KAK + DG V++
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIR 43
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 12/124 (9%)
Query: 37 SNLISRGGFGSIYKA--------KIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ 88
+ ++ G FG +Y+ KI ++ K L F + E +MK + H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKNLDHP 73
Query: 89 NLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 148
+++K+I ++ +I+E P+G LG L + L + + + A+ YL
Sbjct: 74 HIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 149 HSTH 152
+ H
Sbjct: 133 NCVH 136
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 259 FYQML-------LAVQYLHENGIIHRDLKPENVLLSSQ 289
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 29.3 bits (64), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 26/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 56 GMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHG 113
G+E K N + A F+ L+ E + + ++H N++++ S ++ F L+ + + G
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90
Query: 114 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYM 173
L + + + + H + + ++ Y H H LK + L + +
Sbjct: 91 ELFEDIVAREFYSE-ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 149
Query: 174 APDTYNFGIMI 184
A +FG+ I
Sbjct: 150 A----DFGLAI 156
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 26/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 56 GMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHG 113
G+E K N + A F+ L+ E + + ++H N++++ S ++ F L+ + + G
Sbjct: 30 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 89
Query: 114 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYM 173
L + + + + H + + ++ Y H H LK + L + +
Sbjct: 90 ELFEDIVAREFYSE-ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 148
Query: 174 APDTYNFGIMI 184
A +FG+ I
Sbjct: 149 A----DFGLAI 155
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 32/155 (20%), Positives = 66/155 (42%), Gaps = 11/155 (7%)
Query: 33 LFSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQN 89
LF E + +G F + + K E K N + A + L+ E + ++++H N
Sbjct: 35 LFEE---LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 91
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 149
++++ S S++ F L+ + + G L + + Y + H + + +V ++H
Sbjct: 92 IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-ADASHCIHQILESVNHIHQHD 150
Query: 150 STHLLLKEDQSLTQIQTLATISYMAPDTYNFGIMI 184
H LK + L + +A +FG+ I
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLA----DFGLAI 181
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 26/131 (19%), Positives = 56/131 (42%), Gaps = 7/131 (5%)
Query: 56 GMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHG 113
G+E K N + A F+ L+ E + + ++H N++++ S ++ F L+ + + G
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90
Query: 114 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQTLATISYM 173
L + + + + H + + ++ Y H H LK + L + +
Sbjct: 91 ELFEDIVAREFYSE-ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKL 149
Query: 174 APDTYNFGIMI 184
A +FG+ I
Sbjct: 150 A----DFGLAI 156
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 120 FYQMLL-------AVQYLHENGIIHRDLKPENVLLSSQ 150
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 63/279 (22%), Positives = 98/279 (35%), Gaps = 81/279 (29%)
Query: 33 LFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 92
LF++ + I +G FG +YK EVV A K +D+E +I Q I
Sbjct: 20 LFTKLDRIGKGSFGEVYKGIDNHTKEVV----------AIKIIDLEEAEDEIEDIQQEIT 69
Query: 93 IISSCS------------KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 140
++S C K +I+E + GS L + I+ ++
Sbjct: 70 VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREILK 127
Query: 141 AVEYLHFGHSTH-------LLLKEDQSL-------------TQIQT---LATISYMAP-- 175
++YLH H +LL E + TQI+ + T +MAP
Sbjct: 128 GLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 187
Query: 176 ----------DTYNFGIMIMETFSGKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLL 225
D ++ GI +E G+ P +DL P V+ ++ N
Sbjct: 188 IKQSAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFLIPKNSP 233
Query: 226 SREDEHFMTKEQCMSFVFNLAME-CTVESPNQRINAKEM 263
T E S F +E C + P R AKE+
Sbjct: 234 P-------TLEGQHSKPFKEFVEACLNKDPRFRPTAKEL 265
>pdb|3BWW|A Chain A, Crystal Structure Of A Duf692 Family Protein (Hs_1138)
From Haemophilus Somnus 129pt At 2.20 A Resolution
Length = 307
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 14/50 (28%), Positives = 23/50 (46%)
Query: 21 LDLSNNNFSGLFLFSESNLISRGGFGSIYKAKIQDGMEVVVKGFNLQYGG 70
L L NN+ + N I GGF K+ + + +++ G +L GG
Sbjct: 19 LQLRNNDRIQFXEIAPENWIKXGGFARYQFDKVAEKIPILIHGLSLSLGG 68
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 67 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 125
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 126 FYQML-------LAVQYLHENGIIHRDLKPENVLLSSQ 156
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 120 FYQMLL-------AVQYLHENGIIHRDLKPENVLLSSQ 150
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 28.9 bits (63), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 60 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 118
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 119 FYQMLL-------AVQYLHENGIIHRDLKPENVLLSSQ 149
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 28.9 bits (63), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 29/98 (29%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSL------GKCLSTSNYILD 127
N++ E ++K + H +IKI + +D+ ++LE M G L K L + L
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 128 FFQRLHIMIDVASAVEYLHFGHSTHLLLKEDQSLTQIQ 165
F+Q L AV+YLH H LK + L Q
Sbjct: 120 FYQMLL-------AVQYLHENGIIHRDLKPENVLLSSQ 150
>pdb|1D7K|A Chain A, Crystal Structure Of Human Ornithine Decarboxylase At 2.1
Angstroms Resolution
pdb|1D7K|B Chain B, Crystal Structure Of Human Ornithine Decarboxylase At 2.1
Angstroms Resolution
Length = 421
Score = 28.9 bits (63), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
D E +MK+ R K++ + DD KA+ C G L TS +L+ + L+
Sbjct: 126 TFDSEVELMKVARAHPKAKLVLRIATDDSKAV---CRLSVKFGATLRTSRLLLERAKELN 182
Query: 134 IMI 136
I +
Sbjct: 183 IDV 185
>pdb|2OO0|A Chain A, A Structural Insight Into The Inhibition Of Human And
Leishmania Donovani Ornithine Decarboxylases By
3-Aminooxy-1-Aminopropane
pdb|2OO0|B Chain B, A Structural Insight Into The Inhibition Of Human And
Leishmania Donovani Ornithine Decarboxylases By
3-Aminooxy-1-Aminopropane
Length = 471
Score = 28.9 bits (63), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
D E +MK+ R K++ + DD KA+ C G L TS +L+ + L+
Sbjct: 142 TFDSEVELMKVARAHPKAKLVLRIATDDSKAV---CRLSVKFGATLRTSRLLLERAKELN 198
Query: 134 IMI 136
I +
Sbjct: 199 IDV 201
>pdb|2ON3|A Chain A, A Structural Insight Into The Inhibition Of Human And
Leishmania Donovani Ornithine Decarboxylases By
3-Aminooxy- 1-Aminopropane
pdb|2ON3|B Chain B, A Structural Insight Into The Inhibition Of Human And
Leishmania Donovani Ornithine Decarboxylases By
3-Aminooxy- 1-Aminopropane
Length = 461
Score = 28.9 bits (63), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
D E +MK+ R K++ + DD KA+ C G L TS +L+ + L+
Sbjct: 132 TFDSEVELMKVARAHPKAKLVLRIATDDSKAV---CRLSVKFGATLRTSRLLLERAKELN 188
Query: 134 IMI 136
I +
Sbjct: 189 IDV 191
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 28.9 bits (63), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 18/81 (22%), Positives = 37/81 (45%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMID 137
E M ++RH L+ + + D+ +I E M G L + ++ + + + + M
Sbjct: 98 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 138 VASAVEYLHFGHSTHLLLKED 158
V + ++H + HL LK +
Sbjct: 158 VCKGLCHMHENNYVHLDLKPE 178
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 28.5 bits (62), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 18/81 (22%), Positives = 37/81 (45%)
Query: 78 ECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMID 137
E M ++RH L+ + + D+ +I E M G L + ++ + + + + M
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 138 VASAVEYLHFGHSTHLLLKED 158
V + ++H + HL LK +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPE 284
>pdb|7ODC|A Chain A, Crystal Structure Ornithine Decarboxylase From Mouse,
Truncated 37 Residues From The C-Terminus, To 1.6
Angstrom Resolution
Length = 424
Score = 28.5 bits (62), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 18/63 (28%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 74 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLH 133
D E +MK+ R K++ + DD KA+ C G L TS +L+ + L+
Sbjct: 132 TFDSEIELMKVARAHPKAKLVLRIATDDSKAV---CRLSVKFGATLKTSRLLLERAKELN 188
Query: 134 IMI 136
I +
Sbjct: 189 IDV 191
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 28.5 bits (62), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 14/92 (15%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCL 119
+N+I ++ +C++D +I+ G+L + L
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYL 132
>pdb|3GET|A Chain A, Crystal Structure Of Putative Histidinol-Phosphate
Aminotransferase (Np_281508.1) From Campylobacter Jejuni
At 2.01 A Resolution
pdb|3GET|B Chain B, Crystal Structure Of Putative Histidinol-Phosphate
Aminotransferase (Np_281508.1) From Campylobacter Jejuni
At 2.01 A Resolution
Length = 365
Score = 28.5 bits (62), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 17/51 (33%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 73 KNLDVECNMMKIIRHQ-NLIKIISSCSKDDFKALILECMPHGSLGKCLSTS 122
K +C + I H + K + KD+ K LI C+P+ LG+CL S
Sbjct: 124 KQCGAKCYKTQSITHNLDEFKKLYETHKDEIK-LIFLCLPNNPLGECLDAS 173
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 28.5 bits (62), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 43/190 (22%), Positives = 75/190 (39%), Gaps = 38/190 (20%)
Query: 40 ISRGGFGSIYKAKIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 98
I G G + A+ + G +V VK +L+ + L E +M+ +H N++++ S
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 99 KDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHLLLKED 158
+ +++E + G+L +S L+ Q + V A+ YLH H +K D
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 159 QSL---------------TQIQT--------LATISYMAP------------DTYNFGIM 183
L QI + T +MAP D ++ GIM
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 184 IMETFSGKKP 193
++E G+ P
Sbjct: 231 VIEMVDGEPP 240
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 28.1 bits (61), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 39/208 (18%), Positives = 81/208 (38%), Gaps = 50/208 (24%)
Query: 38 NLISRGGFGSIYKAKIQDG--------MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 89
++ +GG+G +++ + G M+V+ K ++ + E N+++ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH--- 146
++ +I + LILE + G L L ++ + + +++ A+ +LH
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-LAEISMALGHLHQKG 141
Query: 147 ------------FGHSTHLLLKE---------DQSLTQIQTLATISYMAP---------- 175
H H+ L + D ++T TI YMAP
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEILMRSGHNR 200
Query: 176 --DTYNFGIMIMETFSGKKPTIKFFHGE 201
D ++ G ++ + +G P F GE
Sbjct: 201 AVDWWSLGALMYDMLTGAPP----FTGE 224
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 28.1 bits (61), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 26/122 (21%), Positives = 55/122 (45%), Gaps = 10/122 (8%)
Query: 32 FLFSESNLISRGGFGSIYKAKIQD--------GMEVVVKGFNLQYGGAFKNLDVECNMMK 83
+F+ES + +G F I+K ++ EV++K + + ++ +MM
Sbjct: 10 LIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 84 IIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVE 143
+ H++L+ C D L+ E + GSL L + ++ +L + +A+A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 144 YL 145
+L
Sbjct: 128 FL 129
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 28.1 bits (61), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 91 IKIISSCSKDDFKALILECM 110
+K++ ++ L+ E +
Sbjct: 65 VKLLDVIHTENKLYLVFEFL 84
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 28.1 bits (61), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 91 IKIISSCSKDDFKALILE 108
+K++ ++ L+ E
Sbjct: 64 VKLLDVIHTENKLYLVFE 81
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 28.1 bits (61), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 39/208 (18%), Positives = 81/208 (38%), Gaps = 50/208 (24%)
Query: 38 NLISRGGFGSIYKAKIQDG--------MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 89
++ +GG+G +++ + G M+V+ K ++ + E N+++ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH--- 146
++ +I + LILE + G L L ++ + + +++ A+ +LH
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-LAEISMALGHLHQKG 141
Query: 147 ------------FGHSTHLLLKE---------DQSLTQIQTLATISYMAP---------- 175
H H+ L + D ++T TI YMAP
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH-XFCGTIEYMAPEILMRSGHNR 200
Query: 176 --DTYNFGIMIMETFSGKKPTIKFFHGE 201
D ++ G ++ + +G P F GE
Sbjct: 201 AVDWWSLGALMYDMLTGAPP----FTGE 224
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 28.1 bits (61), Expect = 5.3, Method: Compositional matrix adjust.
Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 11/95 (11%)
Query: 40 ISRGGFGSIYKAKIQD-GMEVVVKGF-NLQYGGAFKNLDV-ECNMMKIIRHQNLIKIISS 96
I G +G ++K + +D G V +K F + K + + E M+K ++H NL+ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 97 CSKDDFKALILECMPHGSLGKCLSTSNYILDFFQR 131
+ L+ E C T + LD +QR
Sbjct: 71 FRRKRRLHLVFE--------YCDHTVLHELDRYQR 97
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 28.1 bits (61), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 91 IKIISSCSKDDFKALILECM 110
+K++ ++ L+ E +
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 28.1 bits (61), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 91 IKIISSCSKDDFKALILECM 110
+K++ ++ L+ E +
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 28.1 bits (61), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 81
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 28.1 bits (61), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 91 IKIISSCSKDDFKALILECM 110
+K++ ++ L+ E +
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|1C7N|A Chain A, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|B Chain B, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|C Chain C, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|D Chain D, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|E Chain E, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|F Chain F, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|G Chain G, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7N|H Chain H, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal 5'-Phosphate Cofactor
pdb|1C7O|A Chain A, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|B Chain B, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|C Chain C, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|D Chain D, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|E Chain E, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|F Chain F, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|G Chain G, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
pdb|1C7O|H Chain H, Crystal Structure Of Cystalysin From Treponema Denticola
Contains A Pyridoxal
5'-Phosphate-L-Aminoethoxyvinylglycine Complex
Length = 399
Score = 28.1 bits (61), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 33/134 (24%), Positives = 55/134 (41%), Gaps = 27/134 (20%)
Query: 77 VECNMMK-----IIRHQNLIKIISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQR 131
+EC +++ I Q L K+ SKD +L C PH +G+ D Q+
Sbjct: 138 IECELLEKDGYYTIDFQKLEKL----SKDKNNKALLFCSPHNPVGRVWKK-----DELQK 188
Query: 132 LHIMI---DVASAVEYLHF-----GHSTHLLLKEDQSLTQIQTLATISYMAPD-TYNFGI 182
+ ++ D+ + +HF G+ + D+ L TI++ AP T+N
Sbjct: 189 IKDIVLKSDLMLWSDEIHFDLIMPGYEHTVFQSIDEQLAD----KTITFTAPSKTFNIAG 244
Query: 183 MIMETFSGKKPTIK 196
M M K P I+
Sbjct: 245 MGMSNIIIKNPDIR 258
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 28.1 bits (61), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 91 IKIISSCSKDDFKALILECM 110
+K++ ++ L+ E +
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 28.1 bits (61), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 81
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 28.1 bits (61), Expect = 5.8, Method: Compositional matrix adjust.
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 14/94 (14%)
Query: 40 ISRGGFGSIY--------KAKIQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKII-RH 87
+ G FG + K K ++ + V VK L+ K+L E MMK+I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 88 QNLIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+N+I ++ +C++D +I+ G+L + L
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRA 134
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 27.7 bits (60), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 20/80 (25%), Positives = 39/80 (48%), Gaps = 3/80 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 91 IKIISSCSKDDFKALILECM 110
+K++ ++ L+ E +
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 27.7 bits (60), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 81
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 27.7 bits (60), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 82
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 83 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 114
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 27.7 bits (60), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 81
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 27.7 bits (60), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 34 FSESNLISRGGFGSIYKAKIQDGMEVV-VKGFNL--QYGGAFKNLDVECNMMKIIRHQNL 90
F + I G +G +YKA+ + EVV +K L + G E +++K + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 91 IKIISSCSKDDFKALILE 108
+K++ ++ L+ E
Sbjct: 68 VKLLDVIHTENKLYLVFE 85
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 27.7 bits (60), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 81
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 82 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 113
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 27.7 bits (60), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 78
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 79 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 110
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 27.7 bits (60), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 53/265 (20%), Positives = 95/265 (35%), Gaps = 66/265 (24%)
Query: 39 LISRGGFGSIYKA--KIQDGMEVVVKGFNLQYGGAFK---NLDVECNMMKIIRHQNLIKI 93
+I G FG + K+ E+ V L+ G K + E ++M H N+I +
Sbjct: 14 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHL 153
+K +I E M +GSL L ++ Q + ++ +A+ ++YL + H
Sbjct: 74 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 133
Query: 154 LLK-----------------------EDQSLTQIQTLA-----TISYMAP---------- 175
L ED + T A I + AP
Sbjct: 134 ALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 193
Query: 176 --DTYNFGIMIMETFS-GKKPTIKFFHGEMTLKHWVNDLLPNSVMKVVSANLLSREDEHF 232
D +++GI++ E S G++P + +MT + +N + +D
Sbjct: 194 ASDVWSYGIVMWEVMSYGERP-----YWDMTNQDVINAI---------------EQDYRL 233
Query: 233 MTKEQCMSFVFNLAMECTVESPNQR 257
C S + L ++C + N R
Sbjct: 234 PPPMDCPSALHQLMLDCWQKDRNHR 258
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 27.7 bits (60), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 21/95 (22%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 33 LFSESNLISRGGFGSIYK-AKIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQN 89
LF E + +G F + + K+ G E N + A + L+ E + ++++H N
Sbjct: 15 LFEE---LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLSTSNY 124
++++ S S++ LI + + G L + + Y
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 27.3 bits (59), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 13/92 (14%)
Query: 40 ISRGGFGSIYKAKIQDGME------VVVKGFN----LQYGGAFKNLDVECNMMKIIRHQN 89
+ +G FG +Y+ +D ++ V VK N L+ F N E ++MK +
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTCHH 80
Query: 90 LIKIISSCSKDDFKALILECMPHGSLGKCLST 121
+++++ SK +++E M HG L L +
Sbjct: 81 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRS 112
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 27.3 bits (59), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 39 LISRGGFGSIYKA--KIQDGMEVVVKGFNLQYGGAFK---NLDVECNMMKIIRHQNLIKI 93
+I G FG + K+ E+ V L+ G K + E ++M H N+I +
Sbjct: 40 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 94 ISSCSKDDFKALILECMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 145
+K +I E M +GSL L ++ Q + ++ +A+ ++YL
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 151
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.136 0.394
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,200,535
Number of Sequences: 62578
Number of extensions: 277686
Number of successful extensions: 1298
Number of sequences better than 100.0: 404
Number of HSP's better than 100.0 without gapping: 126
Number of HSP's successfully gapped in prelim test: 278
Number of HSP's that attempted gapping in prelim test: 1046
Number of HSP's gapped (non-prelim): 450
length of query: 263
length of database: 14,973,337
effective HSP length: 97
effective length of query: 166
effective length of database: 8,903,271
effective search space: 1477942986
effective search space used: 1477942986
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 50 (23.9 bits)